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Despite being exposed to microbial and food antigens, the human gastrointestinal tract 
does not exist in a state of inflammation. This homeostasis is critically dependent on the colonic 
epithelial barrier, which when dysfunctional is associated with inflammatory bowel disease 
(IBD), obesity and type two diabetes. Limitations in current models of the colonic epithelial 
barrier have driven the development of human colonic organoids, organotypic 3D models of 
the colonic epithelium derived from colonic stem cells. While colonic organoids are an exciting 
new model, they contain only 2-5% goblet cells, a critical secretory component of the barrier, 
in contrast to the ~50% expression seen in native colonic tissue.   
High Wnt and Notch signalling promotes the differentiation of intestinal epithelial stem 
cells into the absorptive lineage, at the expense of the secretory lineage. The maintenance of 
colonic organoids requires high Wnt and Notch signalling, which we hypothesised was 
suppressing the differentiation of colonic stem cells into goblet cells. Our aim was to determine 
if reducing Wnt and Notch signalling in colonic organoids increases the expression of goblet 
cells. Additionally, this study characterised the growth of organoids in high Wnt and Notch 
conditions, quantifying any changes observed in low Wnt and Notch conditions.   
Human colonic organoids derived from biopsy were grown in low Wnt3a conditioned 
media (Wnt3a-CM, 0, 5, 10, 25 and 50%) and Notch signalling was inhibited with DAPT (5 
µM, N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester). The expression 
of goblet cells was determined by labelling with alcian blue and MUC2 staining, while 
quantitative polymerase chain reaction (qPCR) was used to quantify MUC2 transcript 
expression. Proliferation was quantified with Ki67 staining. The number and mean diameter, 
as an index of organoid size, were also recorded to assess growth. 
iii 
 
Organoids grown in reduced Wnt3a-CM exhibited no changes in the number of goblet 
cells or organoid differentiation, survival and proliferation, but were significantly smaller 
(P<0.05). To mitigate against endogenous epithelial Wnt production, organoids were grown in 
0% Wnt3a-CM + reduced Rspondin conditioned media (Rspo-CM, 0, 3 and 12%), which is 
critical for Wnt signalling. Reducing Rspo in the absence of Wnt3a significantly increased the 
expression of MUC2 positive cells (P<0.001), but only increased the expression of alcian blue 
positive cells (P<0.0001) in 0% Wnt3a-CM + 12% Rspo-CM. Organoids had significantly less 
Ki67 positive nuclei in the absence of Wnt and Rspo (P<0.01), although their size was 
unchanged.  
DAPT significantly increased the number of alcian blue positive cells (P<0.0001), but 
not MUC2 positive cells or MUC2 transcript expression, suggesting DAPT alters non-MUC2 
mucin expression. DAPT treated organoids were significantly smaller (P<0.0001), although 
the number of Ki67 positive nuclei was only decreased in 5% Wnt3a-CM + DAPT (P<0.05). 
Notch inhibition had no effect on organoid survival.  
Importantly, a majority of the alcian blue positive and MUC2 positive cells observed in 
this study appeared to be immature, lacking the goblet morphology, basal nuclei and dense 
apical staining observed in mature goblet cells.  
These findings demonstrate the modulation of Wnt and Notch signalling can alter the 
expression of goblet cell markers in colonic organoids but is insufficient to drive the 
development of mature goblet cells. It is likely the addition, or exclusion, of factors such as 
lipopolysaccharide (LPS) or SB202190 are required for full goblet cell maturation. The growth 
of human colonic organoids in high Wnt3a-CM supports current hypotheses on organoid 
growth kinetics and demonstrate that the modulation of Wnt and Notch signalling had varied, 
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1.1 The human gastrointestinal tract  
The human gastrointestinal tract is a remarkable and complex organ, which despite being 
continually exposed to a wide range of environmental, microbial and food antigens, does not 
exist in a state of chronic inflammation. This is particularly true in the colon, which maintains 
intestinal homeostasis while being colonised with ~1014 commensal bacteria (Sender et al., 
2016). While the gastrointestinal immune system, which is primarily located in the lamina 
propria underlying the epithelium, plays a crucial role in maintaining intestinal homeostasis, 
the importance of the epithelium itself, and the barrier it forms is being increasingly appreciated 
(Schenk & Mueller, 2008).  
1.2 The colon 
The colon comprises the distal region of the gastrointestinal tract, and in humans is split 
into four distinct regions, the cecum and the ascending, transverse, and descending colon 
(Kararli, 1995). Similar to the remainder of the gastrointestinal tract, the colonic wall is 
comprised of the outermost serosa, the underlying muscularis and submucosa and the innermost 
mucosa (Kararli, 1995). The mucosa, primarily comprised of the colonic epithelial layer, 
establishes a semi-permeable barrier that mediates absorption of digestive products, electrolytes 
and water, while physically preventing the translocation of unwanted hydrophilic luminal 
material into the internal environment (Capaldo et al., 2017). The colonic epithelium is 
comprised of a simple sheet of absorptive and secretory epithelial cells (Fig. 1.1) (Capaldo et 
al., 2017). 
 The absorptive cells of the colon, termed colonocytes, are the primary facilitators of 
absorption (Kunzelmann & Mall, 2002). This function is mediated via apical and basolateral 
transport proteins, which are under tight hormonal regulation (Kunzelmann & Mall, 2002). The 




microbiota, as well as absorption of short chain fatty acids, the products of this fermentation 
(Ruppin et al., 1980; Macfarlane & Macfarlane, 2011). In contrast, the distal region is involved 
in the regulated absorption of water and electrolytes (Kunzelmann & Mall, 2002). 
The second subgroup of epithelial cells within the colonic epithelium are the secretory 
cells. This group includes goblet cells, enteroendocrine cells and the newly discovered deep 
secretory cells (DSCs) (Fig. 1.1) (Kunzelmann & Mall, 2002; Sasaki et al., 2016). Goblet cells, 
which secrete mucus, are the most abundant secretory cell in the colon, comprising ~50% of 
epithelial cell population (Gersemann et al., 2009). Goblet cells also secrete non-mucus factors, 
including Fcγ binding protein, lectin-like zymogen granule 16 and trefoil factor 3 (TFF3) 
(Martini et al., 2017). These proteins form a chemical barrier that limits bacterial-epithelial 
interaction, while also mediating various other roles (Martini et al., 2017). Non-epithelial 
factors also help maintain the colonic epithelial barrier. Specifically, secretory immunoglobulin 
A (sIgA), secreted from B cells residing in the lamina propria, aggregates antigen in the outer 
mucus layer, preventing it from infiltrating the epithelium (Rogier et al., 2014). Intrinsic 
hormonal regulation of the colon is facilitated by enteroendocrine cells, which comprise ~1% 
of the epithelial layer throughout the length of the colon (Schonhoff et al., 2004). The hormones 
secreted by enteroendocrine cells regulate the various functions of the colon, such as water and 





Figure 1.1: The colonic epithelial barrier  
Schematic representation of a colonic epithelial barrier. The colonic epithelial monolayer forms 
invaginations into the lamina propria to form colonic crypts. At the base of the colonic crypt resides 
a population of stem cells. As daughter cells from the division of the stem cells migrate up the colonic 
crypt they divide further and differentiate into either secretory (goblet, enteroendocrine and deep 
crypt secretory) or absorptive (colonocyte) epithelial cells. Goblets cells secrete mucus, a critical 
component of the epithelial barrier, which organises into the dense inner layer and loose outer layers. 
Due to the density of the inner mucus, the microbiome is restricted to the outer layer. Membrane 
bound mucus produced by all epithelial cells forms the glycocalyx. Intercellular tight junctions (TJs), 
the glycocalyx and secretory IgA (sIgA), produced by B cells within the lamina propria helps to 




1.3 The colonic epithelial barrier  
A critical function of the colonic mucosa is to form a barrier between the luminal contents 
and the internal environment, with evidence linking dysfunction in this barrier to a range of 
systemic and intestinal diseases such as inflammatory bowel disease (IBD) (Jenkins et al., 1988; 
Zeissig et al., 2007; Cox et al., 2017). The colonic epithelial barrier is comprised of three 
primary components: the epithelial monolayer, the stratified mucus layers and the intercellular 
tight junctions (TJs) (Capaldo et al., 2017). 
1.3.1 Epithelial turnover 
One of the most important, and often neglected, properties of the colonic epithelial barrier 
is the rapid turnover of the epithelium itself. The colonic lumen is an extremely noxious 
environment in which cells undergo both physical and chemical assault, resulting in the constant 
death of epithelial surface cells. The colonic epithelium forms a physical barrier which separates 
the internal and external environments and is, therefore, a crucial component of the epithelial 
barrier. The constant death of the surface epithelium is compensated for by a population of crypt 
base columnar stem cells that reside in the basal region of the crypt (Fig. 1.1) (Kosinski et al., 
2007). Crypt base columnar stem cell are quiescent, slowly dividing to give rise to transit 
amplifying (TA) cells (Barker et al., 2008). These rapidly dividing daughter cells reside in a 
stem cell niche which promotes proliferation while inhibiting differentiation (Kosinski et al., 
2007; Barker et al., 2008). As TA cells divide, they migrate up the crypt, where a change in 
niche inhibits proliferation and promotes differentiation into either secretory or absorptive 
progenitors (Kosinski et al., 2007; Barker et al., 2008). Progenitor cells are fully differentiated 
they reach the surface of the crypt, where after a few days they are shed and replaced (Barker, 
2014). This process of renewal is rapid, with the epithelium being completely renewed every 




intestinal epithelial stem cells are lost, which in the small intestine results in flattening of the 
villi and loss of crypt structure (Fevr et al., 2007; Flanagan et al., 2015). 
1.3.2 Tight junctions 
A critical function of the colonic epithelium is to establish a semi-permeable barrier that 
allows the selective transepithelial flux of nutrients, electrolytes and water while preventing 
translocation of any unwanted material (Capaldo et al., 2017). There are two pathways in which 
these substances can be absorbed; through the cell (transcellular flux) and between the cells 
(paracellular flux) (France & Turner, 2017). As mentioned previously, transcellular flux is 
mediated by a series of apical and basolateral transporter and channel proteins, which allow 
both passive and active transport of luminal contents across the cell (Kunzelmann & Mall, 
2002). In comparison, paracellular flux is the passive movement of luminal contents across the 
epithelium via the space between cells, termed the paracellular pathway (Capaldo et al., 2017). 
The primary player in the regulation of paracellular flux are the tight junctions (TJs) (Fig. 1.1) 
(France & Turner, 2017). Tight junctions are the most apical component of the apical junctional 
complex, which also contain adherens junctions and desmosomes (Hartsock & Nelson, 2008). 
Tight junctions are specialised intercellular complexes that bind the apicolateral membranes of 
two adjacent epithelial cells, forming a paracellular seal that maintains epithelial polarity and 
regulates paracellular flux (Hartsock & Nelson, 2008). In the colon, the majority of the water 
and electrolyte absorption occurs via the transcellular pathway, due to a ‘tight’ paracellular 
barrier formed by the TJs (Kunzelmann & Mall, 2002). 
1.3.3 Mucus 
Mucus is one of the primary components of the colonic epithelial barrier (Fig. 1.1) 
(Capaldo et al., 2017). Mucins, a family of heavily O-linked glycosylated glycoproteins, are 




bound (Kim & Ho, 2010). Secreted mucus is a dense, viscous gel produced exclusively by 
goblet cells that self-assembles into a dense network, forming the inner and outer layer of 
colonic mucus (Fig. 1.1). In contrast, membrane bound mucus is synthesised by, and expressed 
on, the apical membrane of all epithelial cells, forming the glycocalyx (Fig. 1.1) (Kim & Ho, 
2010).  
1.3.3.1 Secretory mucus  
In the colon, mucin 2 (MUC2) is the predominant secreted mucin and is largely 
considered the skeleton of intestinal mucus (Tytgat et al., 1994; Johansson et al., 2011). Like 
most secretory mucins, MUC2 is comprised of a backbone rich in proline, threonine and serine 
(PTS) in tandem repeats, which undergo heavy O-linked glycosylation. O-linked glycosylation 
provides mucus with a variety of properties which are crucial in maintaining barrier integrity. 
In mice, inhibition of Muc2 glycosylation with core 1-derived O-glycans allows bacteria to 
penetrate the inner mucus layer, inducing spontaneous colitis (Fu et al., 2011). In addition, O-
glycans provide MUC2 with increased resistance to bacterial proteases (van der Post et al., 
2013). Once secreted into the colonic lumen, MUC2 becomes hydrated, rapidly expanding up 
to 1000-fold, before self-organising into a distinct stratified structure, containing an inner and 
outer layer (Fig. 1.1) (Quinton, 2010; Capaldo et al., 2017). Above the glycocalyx, tightly cross-
linked MUC2 form a dense inner layer, which is impenetrable to bacteria (Johansson et al., 
2014). As mucus turnover takes place, the inner layer undergoes proteolytic expansion forming 
the less dense outer layer (Johansson et al., 2014). Proteolytic expansion occurs when 
endogenous and exogenous proteases break down the disulfide bonds between two MUC2 
mucins, allowing the MUC2 network to expand and solubilise (Sonnenburg et al., 2005). The 
decreased density of the outer layer provides a niche in which bacteria thrive, forming a 




The secreted mucus layer in the colon provides protection from the microbiota and 
luminal contents in a variety of ways. Firstly, mucus lubricates the colon, helping prevent 
mechanical damage to the epithelial monolayer from the passing faeces. The varying densities 
of the mucus layers also prevent the translocation of the microbiota through the inner layer and 
glycocalyx, restricting bacteria to the loose outer layer (Johansson et al., 2014). Thirdly, as 
proteolytic expansion pushes mucus into the colonic lumen, bacteria are pushed with it, 
allowing intestinal peristalsis to remove them into the faeces (Sonnenburg et al., 2005). A final 
means of protection comes from the presence of antimicrobial peptides (AMPs) such as Human 
Beta Defensin 1, 2, and 4 (HBD-1, -2, -4) and sIgA within the mucus (Antoni et al., 2013; 
Rogier et al., 2014). In human rectal mucus, AMPs such as HBD-1 are bound to mucin, 
highlighting the mucus layer as a comprehensive physical and chemical barrier against 
microbial-epithelia interaction (Antoni et al., 2013). Unfortunately, this study investigated the 
mucus as a whole and therefore did not determine whether AMPs were present in the inner or 
outer layer. 
1.3.3.2 Membrane bound mucus 
The glycocalyx is a glycoprotein matrix, primarily comprised of membrane bound 
mucins, that acts as a ‘coat’, covering the apical membrane of intestinal epithelial cells (Fig. 
1.1). Like secreted MUC2, membrane bound mucins, which in the colon are primarily Muc3, 
12 and 17, contain heavily O-linked glycosylated PTS domains (El Homsi et al., 2007; Senapati 
et al., 2010; Yamamoto-Furusho et al., 2015). The extracellular domain of membrane bound 
mucins extends 200-1500 nm from the epithelial layer into the lumen (Kim & Ho, 2010; 
Capaldo et al., 2017). This helps to regulate the interaction between any luminal contents and 
the epithelium, forming a size selective barrier (Frey et al., 1996). The glycocalyx also helps to 
protect the epithelium from any abrasion that occurs during peristaltic propulsion of faeces. The 




apoptotic properties while also modulating signal transduction and proliferation (Ho et al., 
2006). Similarly, Muc4, another transmembrane mucin found in the colon, promotes 
cytoprotection while also playing a role in various signalling pathways (Workman et al., 2009; 
Das et al., 2016).  
1.4 Epithelial barrier dysfunction 
In recent years there has been increasing interest in the relationship between dysfunction 
in the intestinal epithelial barrier and diseases, such as type 2 diabetes mellitus, coeliac disease 
and IBD (Jenkins et al., 1988; Smecuol et al., 1997; Zeissig et al., 2007; Cox et al., 2017). 
Inflammatory bowel disease, which comprises Crohn’s disease (CD) and ulcerative colitis 
(UC), is an autoimmune disease characterised by chronic or transient inflammation of the 
intestinal mucosa (Kaplan, 2015). While it is recognised that other events, such as microbial 
dysbiosis or environmental factors are linked to IBD, dysfunction in the intestinal epithelial 
barrier is of significant interest (Lane et al., 2017). Whether barrier dysfunction is causative, or 
a result of initial inflammation, is currently debated, however, it is generally agreed that barrier 
dysfunction plays a role. 
1.4.1 Dysfunction in the stratified mucus layer is linked to IBD 
In patients with IBD, intestinal biopsies have shown a decrease in both the thickness of 
the mucus layer and the number of goblet cells (Pullan et al., 1994). Polymorphisms in mucins 
have also been identified in people suffering from IBD, some of which result in aberrant mucin 
structure (Kyo et al., 1999; Moehle et al., 2006; Visschedijk et al., 2016). This evidence implies 
a direct link between dysfunction in secreted mucus and IBD pathophysiology.  
Murine models have been used to further characterise this link. Muc2 knockout mice 




adhesion to the intestinal mucosa (Van der Sluis et al., 2006). These mice also develop 
spontaneous colitis, while being more susceptible to dextran sodium sulfate (DSS) induced 
colitis. The Winnie and Eeyore mouse models, which express a missense mutation in the Muc2 
gene, displayed altered Muc2 oligomerisation, as well as increased endoplasmic reticulum (ER) 
stress due to an accumulation of immature mucus (Heazlewood et al., 2008). Endoplasmic 
reticulum stress due to an accumulation of unfolded proteins elicits the unfolded protein 
response, which when chronically active induces apoptosis of the cell (Fribley et al., 2009; 
Wakeman et al., 2012a). In addition, ER stress has previously been linked with the induction 
of an inflammatory response, suggesting another mechanism in which atypical MUC2 synthesis 
can induce barrier dysfunction and subsequent disease (Zhang & Kaufman, 2008). Interestingly 
the pattern of MUC2 accumulation and subsequent ER stress has been observed in human UC 
patients (Heazlewood et al., 2008). Aberrant MUC2 glycosylation led to a phenotype consisting 
of decreased mucus secretion, diminished Muc2 theca storage, increased goblet cell apoptosis, 
increased intestinal permeability, the development of spontaneous colitis, and an increased 
susceptibility to DSS induced colitis (Heazlewood et al., 2008). 
1.4.2 Dysfunction in the tight junction complex is linked to IBD 
As seen in almost every murine model of IBD, increased intestinal permeability, primarily 
representing a change in the paracellular pathway, is associated with colitis. The link between 
an increase in intestinal permeability and the development of IBD arose from an investigation 
into the healthy 1st degree relatives of CD patients (Katz et al., 1989). A subpopulation of these 
relatives exhibited an asymptomatic increase in intestinal permeability compared with controls 
(Katz et al., 1989; May et al., 1993). It has also been reported that in one instance a healthy 1st 
degree relative developed CD 8 years after the discovery she had increased intestinal 
permeability, suggesting increased intestinal permeability as an early pathophysiological step 




permeability has also been associated with an increased risk of relapse in IBD patients in 
remission (Wyatt et al., 1993).  
Further investigation into the tight junction complex in IBD has demonstrated that in the 
disease state this complex undergoes a marked change in claudin expression. Claudins are the 
component of TJs that regulate the permeability of the complex (Günzel & Yu, 2013). Analysis 
of colonic samples from UC and CD patients show a significant upregulation of claudin-2 
(Zeissig et al., 2007; Oshima et al., 2008). Functionally this would result in an increased 
intestinal permeability to small cations and water (Amasheh et al., 2002; Rosenthal et al., 2010). 
In addition, barrier-enhancing claudin-4, claudin-5 and claudin-8 are downregulated in UC and 
CD, respectively, further explaining the increased permeability seen in IBD (Zeissig et al., 
2007). Unfortunately, it is unknown whether there are changes in claudin expression in 1st 
degree relatives exhibiting increased intestinal permeability, and it is therefore not known if 
changes in claudin expression are a cause, or consequence of disease. There is, however, 
evidence for the latter, with claudin-2 upregulation occurring in response to pro-inflammatory 
cytokines commonly seen in IBD, namely tumour necrosis factor α (TNF-α) and interleukin-13 
(IL-13) (Bruewer et al., 2003; Zeissig et al., 2007; Singh et al., 2016). Moreover, TNF-α 
induces aberrant localisation of barrier-enhancing claudin-5 and claudin-8 (Zeissig et al., 2007).  
In summary, IBD is a vastly multifactorial and complex disease, the pathophysiology of 
which is under constant debate. One limitation in the study of IBD is the lack of a representative 
model of the colonic epithelium. However, a new model grown from patient derived stem cells 
offers an exciting new method to study the colonic epithelium in healthy and disease states 




1.5 Modelling the colonic epithelium 
1.5.1 Current models of the colonic epithelium 
To understand the pathophysiology of barrier mediated diseases, and develop novel 
therapies to treat them, establishing an in vitro model of the human intestinal epithelium is 
critical. Although both in vitro and in vivo models are available, there is increasing criticism 
and controversy regarding their limitations (Balimane & Chong, 2005; Seok et al., 2013; Takao 
& Miyakawa, 2015). Human intestinal cell lines, including Caco-2 cells, are often used when 
studying the colonic epithelium. While being representative in that a polarised epithelial 
monolayer is formed, Caco-2 cells do not form a 3D structure as seen in vivo, and therefore 
have no luminal microenvironment (Balimane & Chong, 2005). Furthermore, these cells have 
a lower expression of marker mRNAs found in mature epithelial cells, such as MUC2 (goblet 
cells) and chromograninA (enteroendocrine cells) when compared with native tissue (Kasendra 
et al., 2018). Animal models, especially rodents, are often utilised, although there are significant 
disadvantages in employing rodent models to investigate the colonic epithelial barrier. 
Importantly, mice have a vastly different microbiota to humans, with only 4% of the microbial 
genes in mice being found in humans (Xiao et al., 2015). Moreover, the microbial composition 
differs between mouse strains from different providers (Xiao et al., 2015; Hugenholtz & de 
Vos, 2018). Research into the genomic response to inflammation in mice also identified a 
significant disparity when compared with the response in humans, and other mouse models 
(Seok et al., 2013). It is also important to note that of the 1/3 of highly cited animal intervention 
research later tested in humans, only 8% of the interventions passed Phase 1 of clinical trials, 
highlighting the importance of developing an in vitro human model (Mak et al., 2014). In 
response, intestinal organoids that mimic the functional and structural components of the 
intestinal epithelium, without the associated limitations of cell line and murine models, have 




1.5.2 Organoids: a novel model of the colonic epithelial monolayer 
Organoids are in vitro organotypic cultures derived from adult stem cells within tissue 
samples (whole tissue or biopsy), embryonic stem cells or induced pluripotent stem cells (Sato 
et al., 2009; Sato et al., 2011a; Fatehullah et al., 2016). Having first been grown using murine 
intestinal epithelial stem cells, Sato et al., 2011 developed a technique in which adult human 
intestinal epithelial stem cells, from either the small intestine or colon, could be used to grow 
organoids. For colonic organoids, this method relies on the presence of a range of growth 
factors, such as Wnt3a and Rspondin (Rspo), to promote and maintain colonic epithelial stem 
cell homeostasis (Sato et al., 2011a). After isolation, colonic epithelial stem cells derived from 
human tissue initially arrange into 3D structures called spheroids, which are comprised of an 
undifferentiated simple squamous epithelium. After ~4 d spheroids begin to differentiate, 
forming a convoluted simple columnar epithelium named a colonoid. Spheroid cells are 
proposed to represent TA cells, as they have a much greater proliferative capacity compared to 
colonoids, which in turn are believed to represent the mature surface epithelium (Gadeock & 
Butt, pers. comm., unpublished). This proposal is not without criticism, as cells comprising 
colonoids often express a range of stem cell markers, suggesting colonoid cells are not fully 
mature (Gadeock & Butt, pers. comm., unpublished).  
As colonic organoids consist of only an epithelial monolayer, they are a powerful model 
to investigate intestinal epithelial processes, including the development of TA cells into mature 
epithelial cells, or identifying any physiological differences between IBD and healthy tissue. 
However, one of the limitations of colonic organoids is the frequency of differentiated progeny, 
specifically goblet cells, does not reflect that of the native tissue. In the native colonic 
epithelium goblet cell frequency is between 30-50% (Gersemann et al., 2009), while in 
colonoids, numbers only reach 2-5% (Gadeock & Butt, pers. comm., unpublished). 




cell expression in murine models (van Es et al., 2005), is not effective at increasing goblet cell 
numbers in colonic organoids (Fan & Butt, pers. comm., unpublished). This low expression of 
goblet cells suggests the current protocols to grow colonic organoids are promoting aberrant 
lineage specification.  
1.6 Lineage specification in the colon 
In order to maintain intestinal homeostasis, the colon requires a rapidly proliferating 
population of TA cells. Rapid proliferation is driven by the stem cell niche in which these cells 
reside (Sancho et al., 2003). Two of the primary characteristics of the stem cell niche are high 
levels of Wnt and Notch signalling, both of which play a critical role in maintaining the stem 
cell population in the basal crypt in vivo (Sancho et al., 2003; Kuhnert et al., 2004; VanDussen 
et al., 2012). 
1.6.1 The canonical Wnt pathway  
The canonical Wnt pathway is a crucial component of the colonic crypt base stem cell 
niche, playing a central role in the regulation of stem cell proliferation (Ireland et al., 2004; 
Kuhnert et al., 2004). Inhibition of Wnt signalling in vivo, via overexpression of the Wnt 
inhibitor Dickkopf-related protein 1 (Dkk1), or deletion of the Wnt effector β-catenin, results 
in impaired proliferation, cell cycle arrest and a breakdown of the murine small and colonic 
intestinal epithelium (Ireland et al., 2004; Kuhnert et al., 2004). Wnt also helps to regulate 
intestinal epithelial stem cell differentiation. When inhibited in the murine small intestine the 
number of TA cells was significantly decreased, coinciding with a significant increase in 
absorptive cell expression (Fevr et al., 2007). Furthermore, these mice did not exhibit any 
significant increase in caspase-3 staining, indicating colonic epithelial stem cells differentiate 
into enterocytes in the absence of Wnt. When Wnt binds to the Frizzled (Fzd)/low-density 




destruction complex is inhibited (Fig. 1.2). As a result, β-catenin accumulates within the 
cytoplasm, and can freely translocate to the nucleus. Once in the nucleus, β-catenin forms a 
complex with the transcription factors Lymphoid enhancer-binding factor (LEF) and T-cell 
factor (TCF), initiating the transcription of Wnt target genes, some of which regulate stem cell 
proliferation (Fig. 1.2) (Hoverter et al., 2012; Pate et al., 2014). In the absence of Wnt the 
destruction complex forms, subsequently phosphorylating β-catenin to tag it for ubiquitin 
mediated degradation (Fig. 1.2). This prevents the translocation of β-catenin to the nucleus and 
therefore inhibits the transcription of Wnt target genes.  
In the gastrointestinal tract Wnt ligands are secreted by both the surrounding mesenchyme 
and the epithelium itself (Valenta et al., 2016). Both sources of Wnt appear to be independently 
capable of maintaining the stem cell niche, as mice in which either mesenchymal or epithelial 
Wnts are knocked out exhibit no macroscopic or microscopic pathology (Valenta et al., 2016). 
In the small intestine, Paneth cells, located in the crypt base, play a crucial role in establishing 
the stem cell niche, secreting a wide range of growth factors such as Wnt3 and epidermal growth 
factor (EGF). When knocked out in vivo, the loss of Paneth cells results in a significant loss of 
Lgr5+ stem cells in the basal crypt (Sato et al., 2011b). Although not present in the colon, a 
Paneth-like cell, the deep secretory cell, is believed to play a similar supportive role in colonic 





Figure 1.2: The canonical Wnt signalling pathway 
Schematic representation of the Wnt pathway in the A) absence and B) presence of Wnt. When Wnt is 
absent the destruction complex forms, subsequently phosphorylating β-catenin. This results in the 
ubiquitin mediated degradation of β-catenin, preventing it from translocating to the nucleus to transcribe 
Wnt target genes. When Wnt binds to the Frizzled receptor LRP5/6 complex the destruction complex 
does not form, leading to accumulation of β-catenin in the cytosol. β-catenin can then translocate to the 
nucleus, where it forms a complex with TCF and LEF to initiate the transcription of Wnt target genes 
such as cyclinD1 and c-myc. Redrawn from Mah et al., 2016.  
1.6.2 The Rspondin pathway 
Rspondins are a family of proteins secreted by the colonic mesenchyme that potentiate 
Wnt signalling, and therefore help to maintain intestinal epithelial stem cells (Kim et al., 2005; 
Kang et al., 2016). Of the four known Rspos (Rspo1-4) only Rspo1-3 are present in the human 
colon (Uhlen et al., 2015). When Rspo is absent the transmembrane E3 ubiquitin ligases 
Rnf43/Znrf3 ubiquitinate Fzd and LRP6, tagging them for degradation (Fig. 1.3) (Hao et al., 
2012; Xie et al., 2013; Hao et al., 2016). When present, Rspo binds to the leucine-rich repeat-
containing G-protein coupled receptor 4/5 (Lgr5) and Rnf43/Znrf3 (Fig. 1.3) (Hao et al., 2012; 
Xie et al., 2013; Hao et al., 2016). This induces the auto-ubiquitination and subsequent 




cell membrane (Fig. 1.3). When Lgr4/5 is knocked out of the small intestine there is a significant 
decrease in proliferating intestinal cells, leading to a flattening of the villi and a subsequent 
lethal phenotype (de Lau et al., 2011). In contrast, injection of human Rspo1 into mice markedly 
increases the number of proliferating intestinal cells, which promotes intestinal regeneration 







Figure 1.3: Rspondin potentiation of the canonical Wnt signalling pathway  
Schematic representation of Rspondin (Rspo) potentiation of Wnt signalling. A) When Rspo is absent 
the transmembrane E3 ligase complex Rnf43/Znrf3 ubiquitinates Frizzled (Fzd) and low-density 
lipoprotein receptor-related protein 5/6 (LRP5/6), tagging them for internalisation and subsequent 
degradation. B) When Rspo binds to LGR4/5 the Rnf43/Znrf3 complex is inhibited, resulting in an 
increased expression of Fzd and LRP5/6 is the membrane, potentiating the strength of Wnt signalling. 





1.6.3 The Notch pathway 
The Notch pathway is another crucial component of the stem cell niche. Notch signalling 
occurs via cell-cell contact, where the Delta-like canonical Notch ligand 1-4 (Dll 1-4) on the 
signal sending cell binds to the Notch receptor on the signal receiving cell (Fig 1.4) (Mah et al., 
2016). This leads to cleavage of the Notch Intracellular Domain (NICD) by γ-secretase. NICD 
is then free to translocate to the nucleus, where it forms a complex with the transcription factors 
Co-A and RPB-J, allowing the transcription of Notch genes such as hairy and enhancer of split-
1 (HES1) and Olfactomedin 4 (OLFM4). In the gastrointestinal tract, Notch signalling is 
involved in the regulation of stem cell proliferation and differentiation. Global pharmacological 
inhibition of γ-secretase leads to a significant decrease in Ki67 positive intestinal epithelial stem 
cells, with some becoming apoptotic (VanDussen et al., 2012). This coincides with a significant 
increase in goblet cells. Furthermore, mice that lack the Notch receptors Notch1 and Notch2, 
both of which are expressed on colonic epithelial stem cells, exhibit a similar phenotype, with 
a reduction in Ki67 positive nuclei in the crypt base as well as a significant increase in goblet 





Figure 1.4: The canonical Notch signalling pathway  
Schematic representation of canonical Notch signalling. Dll 1-4 expressed on the surface of the signal 
sending cell binds to the Notch receptor expressed by the signal receiving cell. This activates γ-
secretase, which cleaves the intracellular domain of the Notch receptor (NICD). NICD then 
translocates to the nucleus, where it forms a complex with RBP-J and Co-A, allowing the 
transcription of Notch target genes to occur. Adapted from Demitrack & Samuelson, 2016. 
1.6.4 Modulation of lineage development by Wnt and Notch 
As TA cells divide, they migrate up the colonic crypt, where the niche changes to the 
promote differentiation, while inhibiting proliferation (Fig. 1.5). One of the primary changes in 
this niche is a reduction in Wnt signalling, which becomes less prominent as the TA cells 
migrate up the crypt (Fig. 1.5). It is in this niche where lineage specification into either the 
secretory or absorptive fates takes place. Ensuring the correct ratio of mature epithelial cells is 
critical in maintaining barrier function. As discussed previously, a loss of goblet cells results in 
microbial infiltration and subsequent inflammation in the murine intestine (Van der Sluis, 




loop-helix transcription factors Atonal homologue 1 (ATOH1) and HES1 (Fig. 1.5). ATOH1 
expression promotes differentiation into the secretory lineage, with genetic ablation of the 
murine homologue of ATOH1, mouse atonal homologue 1 (Math1), resulting in a colonic 
epithelium comprised of solely absorptive cells (Yang et al., 2001; Shroyer et al., 2007). 
Conversely, overexpression of Math1 in the developing intestinal epithelium led to a significant 
increase in the proportion of secretory cells (VanDussen & Samuelson, 2010). In contrast, 
HES1 promotes differentiation into the absorptive lineage, with adult Hes1-/- mice exhibiting 
increased mucosecretory cell expression in the small intestine (Zecchini et al., 2005). 
It is widely agreed that the Notch pathway regulates lineage specification via Hes1. 
Constitutive activation of Notch in the murine small intestine upregulates Hes1 while 
downregulating Atoh1 (Fre et al., 2005). Additionally, constitutive Notch signalling resulted in 
a depletion of mucosecretory cells (Fre et al., 2005), whereas Notch inhibition increases the 
goblet cell expression in the colon (van Es et al., 2005). Recent findings suggest the regulation 
of differentiation by Notch occurs via Hes1 mediated downregulation of Atoh1 (Zheng et al., 
2011). Increased Hes1 expression decreases Atoh1, which contains a Hes1 binding site, in a 
Notch dependent manner (Zheng et al., 2011). In contrast, the role of the canonical Wnt 
pathway in lineage specification is controversial, with research suggesting Atoh1 can be both 
upregulated, and downregulated by Wnt signalling (Tsuchiya et al., 2007; Shi et al., 2010). In 
a colon cancer cell line, glycogen synthase kinase 3 beta (GSK3β), a downstream kinase of Wnt 
signalling, was found to switch targets from β-catenin to ATOH1 in the presence of high Wnt, 
tagging it for proteasomal degradation (Tsuchiya et al., 2007; Aragaki et al., 2008). The 
addition of a GSK3β inhibitor restored Atoh1 expression, while significantly increasing Muc2 
expression in these cells (Aragaki et al., 2008). In contrast the Wnt effector β-catenin was found 
to bind to the Atoh1 promotor, increasing Atoh1 expression in murine neural cell lines (Shi et 




binding to the HES1 promotor to upregulate HES1 expression in a colon cancer cell line 
(Rodilla et al., 2009; Peignon et al., 2011). 
 
Figure 1.5: Lineage specification in the colon  
Representative diagram of lineage specification in the colon. Quiescent stem cells reside in the base 
of the colonic crypt, infrequently dividing to give rise to rapidly proliferating transit amplifying (TA) 
cells. TA cells exist in a high Wnt/high Notch niche that promotes proliferation while inhibiting 
differentiation. As TA cells migrate up the crypt this niche changes, promoting differentiation into a 
secretory or absorptive progenitor while inhibiting proliferation. The lineage fate of a TA cell is 
determined by the differential expression of the transcription factors HES1 or ATOH1. As progenitor 
cells further migrate up the crypt they fully differentiate into mature epithelial cells. Redrawn from 





1.7 Aims and hypothesis  
Currently, colonic organoids grown in our laboratory have significantly fewer goblet cells 
than is found in the native tissue.   
Colonic organoids are grown in a high Wnt3a media (organoid growth media) that 
represents the stem cell niche in vivo, promoting stem cell proliferation which is critical for the 
successful growth of the culture (Ireland et al., 2004; Kuhnert et al., 2004; Sato et al., 2011a). 
In addition, colonic organoids have endogenously high levels of Notch signalling (Rodriguez 
& Butt pers. comm., unpublished), another signalling pathway that is critical for stem cell 
proliferation (Riccio et al., 2008; VanDussen et al., 2012). In vivo, high levels of Wnt and Notch 
signalling can drive the transition of intestinal epithelial cells to a cancerous phenotype, in 
which HES1 is high and ATOH1 is low (Kazanjian & Shroyer, 2011; Polakis, 2012). Previous 
research investigating the modulation of lineage development in the colon has demonstrated 
Notch upregulates HES1, which downregulates ATOH1, a transcription factor critical in goblet 
cell differentiation (Yang et al., 2001; van Es et al., 2005; VanDussen & Samuelson, 2010; 
VanDussen et al., 2012). In addition, high levels of Wnt can repress the expression of ATOH1, 
either via the upregulation of HES1 or the degradation of the ATOH1 protein (van de Wetering 
et al., 2002; Aragaki et al., 2008; Rodilla et al., 2009; Peignon et al., 2011). Given these 
findings, it was hypothesised that decreasing Wnt and Notch signalling in colonic organoids 
would result in an increase in ATOH1 and therefore goblet cell expression.   
The first aim of this study was to determine the minimum level of Wnt3a required to 
maintain colonic organoid growth while determining if the reduction in Wnt3a had any effect 
on goblet cell expression. Having found the minimum level of Wnt3a required for organoid 
growth, the second aim of this study was to determine the effect of Notch inhibition at low 




in colonic epithelial stem cell maintenance, this study also characterised the growth of human 
colonic organoids, analysing the effect of Wnt and Notch modulation on organoid 





2.1 Tissue samples  
The tissues used in this study were collected from healthy patients recruited from the 
Dunedin Public Hospital who had not been diagnosed with any inflammatory gastrointestinal 
diseases such as IBD. During either elective colonoscopy or cancer resection, samples of the 
transverse colon were collected. In the event of a bowel resection in which benign or malignant 
tissue was removed, ~2 mm2 samples were collected ~15 cm proximal or distal from the site of 
pathology. 
2.2 Ethics 
All work regarding the collection and long-term culture of human intestinal epithelial 
stem cells was approved by the Health and Disability Ethics Committee. 
2.3 Organoid culture  
2.3.1 Crypt isolation 
Tissue samples were transported to the laboratory in 20 ml Dulbecco’s Modified Eagle 
medium (DMEM, Life Technologies, USA) containing 5% foetal bovine serum (FBS, Gibco®, 
Thermo Fisher Scientific, USA) and the antibiotics normacin (0.1 mg/ml, Integrated Science, 
NZ), fungizone (2.5 µg/ml, Life Technologies, USA), gentamycin (50 µg/ml, Life 
Technologies, USA) and 1% penicillin/streptomycin (Pen/Strep, Life Technologies, 
USA). Samples were first washed in phosphate buffered saline (PBS, in mM 137 NaCl, 2.7 
KCl, 4.3 Na2HPO4, 1.47 KH2PO4, pH 7.4, Life Technologies, USA) to remove any faecal 
material. For resection samples the underlying connective tissue and muscle layers were 
removed via blunt dissection, isolating the epithelial layer which was subsequently cut into ~5 
mm2 pieces. Both resection and biopsy samples were placed in a 15 ml tube containing 10 mM 




no longer visible. Next, samples were incubated in 8 mM, sterile ethylenediaminetetraacetic 
acid (EDTA) in PBS for 60 min on ice. After incubation the EDTA was replaced with ice cold 
PBS, before the tissue was gently shaken to release the colonic crypts. Once the gross tissue 
settled, the crypt enriched supernatant was transferred to a 50 ml tube, at which point FBS was 
added to reach a final concentration of 5%. The gross tissue sample was then resuspended in 
ice cold PBS, and the above steps repeated six to eight times. Then, crypt enriched fractions 
were combined, and the crypts pelleted by centrifuging at 40 g 2 min at 4 °C. The pellet was 
resuspended in DMEM/F12 containing 1% Pen/Strep, normacin (0.1 mg/ml) and 5% FBS 
before being spun down at 40 g for 2 min at 4 °C. The pellet was transferred to a 1.5 ml 
microcentrifuge tube and resuspended in advanced DMEM/F12 containing 5% FBS + 
antibiotics (as above) before a final centrifuge at 0.1 g for 2 min at 4 °C. The crypts were then 
suspended in Matrigel™ before ~ 45 µl was pipetted into the required number of wells of a pre-
warmed (37 °C) 24-well plate (Thermo Fisher Scientific, USA). The plate was incubated at 37 
°C for 10 min to polymerise the Matrigel™ before each well was overlaid with 500 µl of pre-
warmed (37 °C) organoid growth media (Table. 1). Organoids were incubated at 37 °C in a 5% 
CO2/air mix. 
2.3.2 Passaging  
Unless being used for an experiment, or if growth was insufficient, organoids were 
passaged every 7-10 d to amplify the number of organoids. The media was washed out with 
PBS and the Matrigel™ containing the organoids transferred to a 1.5 ml microcentrifuge tube 
before being incubated in ice cold PBS to depolymerise the Matrigel™. This step was carried 
out until all residue was collected. Once the Matrigel™ was depolymerized, the isolated 
organoids were spun down in a pre-cooled centrifuge (4 °C) at 900 g for 2 min. The supernatant 
was then removed, and the organoids resuspended in ice-cold PBS to reach a final volume of 1 




carefully sucking them through a 25-gauge needle. This was done at least six times to ensure 
sufficient disruption of the organoids. The fragments were then centrifuged at 900 g for 2.5 min 
(4 °C). The supernatant was then carefully removed, and the fragments resuspended in 
Matrigel™. The Matrigel™ (45 µl/well) was then pipetted into the required number of wells in 
a pre-warmed (37 °C) 24-well plate before being overlaid in 500 µl of pre-warmed (37 °C) 
organoid growth media (Table. 1). The media was prepared in 50 ml aliquots and stored at 4 °C 
until required. During the first addition of media immediately after passaging the ROCK 
inhibitor Y-27623 (Merck Millipore, USA) was added to the organoid growth media (Table. 1) 
to reach a final concentration of 10 µM. ROCK is a kinase that regulates apoptosis and 
proliferation in epithelial cells (Shi & Lei et al., 2007). Y-27623 was therefore added to reduce 
apoptosis within the culture (Watanabe et al., 2007). Organoids were cultured in this media for 
2 d, before it was replaced with normal organoid growth media, which was subsequently 
replaced every 2-3 d. 
Table 1: Components included in organoid growth media  
A list of the additives added to the organoid growth media to represent the stem cell niche. The final 
concentration of each additive, along with the supplier, is listed. 
 
Additive Final Concentration Supplier 
Advanced DMEM/F12 - Invitrogen, USA 
B27 1X Invitrogen, USA 
Gastrin 1 µg/ml Pharmaco, NZ 
Glutamax 1X Invitrogen, USA 
Hepes 10 mM Sigma, USA 
Human epidermal growth 
factor 
50 ng/ml Invitrogen, USA 
LY 2157299 500 nM  AxonMedChem, USA 
N2 1X Invitrogen, USA 
N-acetyl-L-cysteine 1 mM Sigma, USA 
Nicotinamide  10 mM Sigma, USA 
Noggin 100 ng/ml PeproTech, USA 
Normacin 0.1 mg/ml Integrated Science, NZ 
Pen/Strep 1% Invitrogen, USA 
Prostaglandin E2 0.01 µM Sigma, USA 
Rspondin conditioned media 12% - 
SB 202190 10 µM Sigma, USA 
Wnt3a conditioned media  50% - 




2.3.3 Reduced Wnt3a conditioned media  
Organoids were only used from passage 2-8 to ensure organoids maintain their epithelial 
phenotype. Organoids were established for 4 d before experimental treatment began. During 
establishment, organoids were incubated in complete organoid growth media (Table. 1). On 
day 4 photographs were taken with a camera (Leica EC3, Leica Biosystems, Germany) mounted 
on a dissecting microscope (Leica DM2700 M), before each well was washed twice for 5 min 
with PBS. This was the standard procedure for all subsequent experiments (Fig. 2.1). The PBS 
was then replaced with media containing either 0, 5, 10, 25 or 50% Wnt3a conditioned media 
(Wnt3a-CM). 50% Wnt3a-CM is the standard amount added to organoid growth media, and 
therefore was our control. Wnt3a-CM was varied by replacing it with appropriate volumes of 
DMEM (1X)/GlutaMAX™-1. The organoids were then grown for a further 11 d at 37 °C, over 
which time the media was replaced with the appropriate experimental media every 2-3 d. 
Although the absolute concentration of Wnt3a present in the Wnt3a-CM is unknown, the same 
batch of Wnt3a-CM was used for all experiments. On day 15, a further set of photos were taken 
before the organoids were processed for histology, immunohistochemistry and 
immunofluorescence.  
2.3.4 Removal of Wnt3a conditioned media + reduced Rspondin 
conditioned media 
Once established, organoids were grown in media containing either 0% Wnt3a-CM + 12% 
Rspondin conditioned media (Rspo-CM), 0% Wnt3a-CM + 0% Rspo-CM, 0% Wnt3a-CM + 
3% Rspo-CM or 50% Wnt3a-CM + 12% Rspo-CM. 12% Rspo-CM is the standard amount 
added to organoid growth media, and therefore was our control. Wnt3a-CM and Rspo-CM was 
varied by replacing it with appropriate volumes of DMEM (1X)/GlutaMAX™-1 (Life 
Technologies, USA). The organoids were then grown for a further 11 d at 37 °C, over which 




batch of Wnt3a-CM and Rspo-CM were used for all experiments. On day 15, a further set of 
photos were taken before the organoids were processed for histology, immunohistochemistry 
and immunofluorescence  
2.3.5 Notch inhibition 
 After establishment organoids were grown in organoid media containing either 5% 
Wnt3a-CM conditioned media ± 5 µM N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-
phenylglycine t-butyl ester (DAPT, a Notch inhibitor, Tocris, UK), 10% Wnt3a-CM ± 5 µM 
DAPT or 50% Wnt3a-CM ± 5 µM DAPT. Wnt3a-CM was varied by replacing it with 
appropriate volumes of DMEM (1X)/GlutaMAX™-1. Organoids were grown for a further 11 
d at 37 °C, over which time the media was replaced with the appropriate experimental media 
every 2-3 d. Although the absolute concentration of Wnt3a present in the Wnt3a-CM is 
unknown, the same batch of Wnt3a-CM was used for all experiments. On day 15, a further set 
of photographs were taken before the organoids were processed for either histology, 






Figure 2.1: Experimental design 
A schematic representation of the standard experimental procedure used throughout the project. 
Organoids were established in 50% Wnt3a-CM for 4 d before being grown in experimental or 
control conditions. Organoids were only used from passage 2-8. All organoids grown in 
experimental and control conditions were derived from the same patient.   
2.4 Tissue processing 
2.4.1 Fixing  
To prepare the organoids for histology, the Matrigel™ containing the 
suspended organoids was washed in cold PBS and then transferred to a 1.5 ml microcentrifuge 
tube. The tubes were incubated on ice for 60 min to depolymerize the Matrigel™. After 
incubation, organoids were centrifuged at 900 g for 2 min at 4 °C. The supernatant was then 
removed, and the pellet resuspended in 1 ml ice-cold PBS. After being centrifuged a second 
time at 900 g for 2 min at 4 °C, the supernatant was removed. The pellet was then resuspended 




shaking platform for 30 min. Next, the organoids were centrifuged at 900 g for 2 min at 4 °C, 
the supernatant removed, and the pellet resuspended in ice-cold PBS. The organoids were then 
pelleted for a final time at 2400 g for 2min at 4 °C. The supernatant was then removed, and the 
pellet resuspended in HistoGel™, which was quickly transferred to a metal histology mould. 
The organoids in HistoGel™ were processed and embedded in paraffin blocks by the specialists 
in the Histology Unit, University of Otago.   
2.4.2 Tissue sectioning  
Wax blocks containing organoids embedded in HistoGel™ were cut into 4 µm sections 
using a standard rotary microtome (Leica RM2235, Leica Biosystems, Germany). Sections 
were flattened out onto 30% ethanol before being floated out in a 40-42 °C water bath. Sections 
were then mounted on either microscope slides (Marienfeld, Germany), used for histology or 
Leica Microsystems Bond Plus Slides (Leica Biosystems, Germany), used for 
immunohistochemistry or immunofluorescence. The slides were dried at 37 °C and baked at 60 
°C for 60 min at which point they were stored at RT or stained.  
2.5 Histological staining 
To visualise mucins within organoids they were stained with alcian blue. Firstly, the 
sections were dewaxed in xylene and rehydrated in 100%, 90% and 70% ethanol and distilled 
H2O (dH2O). Organoids were then stained with alcian blue 0.8 pH (Sigma-Aldrich, USA) for 
30 min, washed in dH2O, and counterstained with nuclear fast red (Sigma-Aldrich, USA) for 5 
min. The sections were then dehydrated in 100% ethanol, rinsed in xylene, and coverslipped 




2.6 Fluorescent immunodetection of MUC2 and Ki67 
Organoid sections were processed onto microscope slides, dewaxed, dehydrated and 
rehydrated as described in section 2.5. Antigen was retrieved by exposing rehydrated slides to 
1 mM EDTA (pH 0.8, Sigma-Aldrich, USA) and microwaving (Panasonic, Japan) at full power 
for 1 min followed by 12 min at 10% power. After cooling to RT for 20 min, sections were 
washed twice in PBS for 2 min each. The sections were then permeabilised using 0.5% Triton 
X-100 (Sigma-Aldrich, USA) in PBS for 45 min, before being washed in PBS 2 times for 2 
min. To ensure specific antigen binding, sections were blocked using 5% normal goat serum 
(NGS, Life Technologies, USA) in PBS for 60 min at RT. After blocking, slides were washed 
twice in PBS for 2 min before being counterstained with a mouse anti-MUC2 primary antibody 
(1:200 dilution in PBS + 1% NGS, #MA1-35701, Invitrogen, USA) overnight at 4 °C in a 
humidified chamber. Sections were washed three times in PBS for 10 min each following 
primary antibody incubation and then incubated with a goat anti-mouse secondary antibody (1 
in 1000 dilution in PBS, Alexa Fluor™ 488, #A20181, Thermo Fisher Scientific, USA) in a 
humidified chamber at RT for 2 h. Following incubation sections underwent three washes in 
PBS for 5 min, before being counterstained with Hoechst (1:1000 dilution in PBS, Invitrogen, 
USA) for 10 min at RT. Sections were washed three times in PBS for 2 min, overlaid with a 
drop of Fluoroshield™ mounting medium (Sigma, USA) and coverslipped (Labserv, Thermo 
Fisher Scientific, USA). The slides were sealed with clear nail polish and stored in the dark at 4 
°C until required. 
Immunofluorescence was also attempted for Ki67 using the protocol described above. 
The primary antibody used was a rabbit anti-Ki67 (1 in 50 dilution in PBS + 1% NGS, #NB500-
170, Sapphire Bioscience, AU), followed by a goat anti-rabbit secondary (1 in 1000 dilution in 
PBS, Alexa Fluor™ 549, #A20185, Thermo Fisher Scientific, USA). When viewed using a 




visualisation difficult (Fig. 2.2). Due to time constraints the decision was made to not attempt 
to optimise the procedure for Ki67 immunofluorescence, but instead employ chromogenic 
immunohistochemistry.   
 
Figure 2.2: Ki67 immunofluorescence in colonoids 
Representative fluorescent microscope images of a colonoid stained for Ki67 using 
immunofluorescence. Images taken with an Olympus BX51 camera at 20x objective. There was a 
high degree of background staining which made identifying Ki67 positive nuclei difficult. 
2.7 Chromogenic immunodetection of Ki67 
Sections were dewaxed as described previously, before being incubated in H2O2 diluted 
in methanol (1:10 dilution) for 10 min. The tissue was then washed in PBS for 1 min, then 
microwaved (KOS Microwave HistoSTATION, Milestone Medical, USA) for 25 min in Tris-
EDTA pH 9.0 for 25 min on the antigen retrieval setting. This setting maintained the 
temperature of the Tris-EDTA and tissue at 95 °C. The tissue was then blocked in 10% bovine 
serum albumin (BSA, Gibco®, Thermo Fisher Scientific, USA) in PBS for 10 min. After being 
washed in PBS, the tissue was incubated with a rabbit anti-Ki67 1° antibody (1:100 dilution in 
PBS + 2% BSA, #NB500-170, Sapphire Bioscience, AU) overnight in a humidified chamber. 
After incubation the tissue was washed three times for 5 min each in PBS + Tween (PBS as 
described above + 0.05% Tween, Sigma-Aldrich, USA), before being incubated with the 
donkey anti-rabbit/mouse horseradish peroxidase (HRP) 2° antibody (1:100 dilution, #NA931 




+ Tween, then incubated with 3,3'-Diaminobenzidine (DAB) in buffer (1 drop DAB to 1 ml 
buffer, Sigma-Aldrich, USA) for 5 min. After staining, the tissue was rinsed in dH2O for 1 min 
before being counterstained with haematoxylin for 5 min and subsequently dehydrated and 
coverslipped as described. Human tonsil epithelium was used as a positive control, as it displays 
an easily recognized Ki-67 staining pattern including strongly positive, weakly positive and 
negative zones (Hsu et al., 2013).  When viewed using the Aperio CSO slide scanner (Leica 
Biosystems, Germany) suboptimal staining was observed (Fig. 2.2). The tissue appeared to 
have lifted off the slide during antigen retrieval, resulting in a section that was difficult to 
analyse. In addition, the human tonsil control also exhibited sub-optimal staining, which was 
much fainter then seen previously (Fig. 2.3). As time was a concern, the decision was made not 
to further optimise manual staining, and instead attempt using a Leica Bond RX Autostainer 
(Leica Biosystems, Germany) in the Histology Unit, University of Otago. 
Organoid sections were processed onto microscope slides as described previously. The 
Leica Bond RX Autostainer was then used to stain organoids for Ki67 using the standard IHC 
protocol F (as per manufacturer’s instructions). First the slides were dewaxed, before heat 
induced epitope retrieval (HIER) was carried out using epitope retrieval solution 1 (ER1, 
sodium citrate buffer pH 6.0, Leica Biosystems, Germany) for 20 min. The tissue was then 
blocked using peroxidase before being incubated in the mouse anti-Ki67 1° antibody (1:50 
dilution in Leica Bond antibody diluent, #M7240, DAKO, USA) for 15 min. Following a series 
of washes the tissue was incubated with a biotinylated 2° antibody (Bond Polymer Refine 
Detection, #DS9800, Leica Biosystems, Germany) for 8 min. The tissue was then incubated 
with an HRP conjugate polymer, washed, then incubated with DAB. Nuclei were 
counterstained using haematoxylin before the sections were dehydrated in 100% ethanol, rinsed 
in xylene, and coverslipped with DPX. Ki67 positive nuclei in colonoids were much clearer 




staining (Fig. 2.3A-B). The human tonsil control was also much clearer compared with the 
manual control, with Ki67 positive nuclei appearing much darker (Fig. 2.3C-D). As there was 
no time to optimise the manual procedure, and the automatic Ki67 staining was successful the 
decision was made to use the Leica Bond RX Autostainer for Ki67 analysis.  
 
Figure 2.3: Comparison of Ki67 staining using the automatic and manual methods 
Representative scanned images of A-B) colonoids and C-D) human tonsil control (grown in 50% 
Wnt3a-CM) stained for Ki67 using the A and C) manual and B and D) automatic methods. Images 
taken at A-B) 15x and C-D) 1x objective. Both colonoid images are of sections from the same 
colonoid. Ki67 positive nuclei are brown, whereas Ki67 negative nuclei are blue. Arrows point to 
Ki67 positive nuclei. Colonoids stained using the manual method exhibited weaker haematoxylin 
staining and appeared to have partially lifted off the microscope slide. The accompanying tonsil 
control had weaker staining of Ki67 positive nuclei. When stained using the automatic method 
both Ki67 positive and negative nuclei were more visible in colonoids. This was also observed in 





2.8 Image analysis 
2.8.1 Analysis of histology and immunohistochemistry  
To identify goblet cells and Ki67 positive nuclei, images of organoids stained using 
histology or immunohistochemistry were captured using the Aperio CSO slide scanner, 
generating images that allowed magnification up to 40x. Images were viewed using Aperio 
Image Scope (Leica Biosystems, Germany) allowing screenshots of individual colonoids to be 
taken for further analysis. When analysing goblet cell number, only colonoids were included. 
Using the cell counter plugin for ImageJ (ImageJ 1.x, USA), the proportion of alcian blue 
positive cells was quantified by counting the total number of cells, and the total number of 
alcian blue positive cells, in colonoids. The proportion of alcian blue positive cells was 
expressed as a percentage of the total number of cells.  
Scanned images of organoids stained for Ki67 were analysed using the Aperio Nuclear 
Algorithm which had been tuned to differentiate between Ki67 positive, and Ki67 negative 
nuclei. In Aperio Image Scope, each organoid was encircled with the pen tool (Fig. 2.4). Any 
artefacts within the encircled area were encircled with the negative pen tool, to prevent the 
algorithm from analysing this area (Fig. 2.4). The algorithm was then used to identify, and count 
the Ki67 positive, and negative, nuclei within the organoid (Fig. 2.4). This was carried out for 
every colonoid, and spheroid, within a section. Ki67 positive nuclei were categorised into three 
groups, based on the intensity of the staining. Based on a comparison of manual and automatic 
counts (Fig. 2.4) it was decided to only consider the two highest intensity groups as Ki67 
positive. The number of Ki67 positive nuclei was expressed as a percentage of the total number 





Figure 2.4: Ki67 analysis using the Aperio Nuclear Algorithm  
A) Images of a colonoid undergoing analysis using the Aperio Nuclear Algorithm. Images taken at 
15x objective. First the organoid was encircled using the pen tool, before the negative pen tool was 
used to encircle any unwanted artefacts or cells. Anything encircled with the negative pen tool was 
excluded by the algorithm. The algorithm was then applied, visually indicating if cells were Ki67 
negative (blue) or weakly (yellow), moderately (orange) or strongly (red) stained for Ki67. Based on 
visual analysis, the decision was made to exclude weakly stained Ki67 positive nuclei and therefore 
consider them Ki67 negative. B) Comparison of the percentage of Ki67 positive nuclei in colonoids 
determined using manual counts or the Nuclear Algorithm. No significant difference was found 
between the two methods (unpaired Student’s t test). N=1, n=3 spheroids and n=34 colonoids. 
2.8.2 Analysis of immunofluorescence  
Organoids stained using immunofluorescence were visualised, and images taken using a 
fluorescent microscope (Olympus BX51, USA) mounted with a camera (Nikon DS-QilMc, 
USA). Images were taken using the NIS-Elements BR software (Nikon, USA) in which images 
were also merged and excess background removed. The proportion of MUC2 positive cells in 




2.8.3 Analysis of mean diameter, number and survival 
Dissecting microscope images of organoids were taken on day 4 and day 15 as described 
previously. For each image the number of spheroids and colonoids was determined using the 
cell counter plugin for ImageJ. The proportion of colonoids and spheroids for each time point 
was then expressed as a percentage of the total number of organoids. Organoid survival was 
expressed as the number of organoids on day 15, as a proportion of the number on day 4. The 
mean diameter of spheroids and colonoids on day 4, and day 15, were also obtained as an index 
of size. Using ImageJ, the length and width of each organoid was determined, and the average 
of the two values calculated. Mean diameter was expressed in µm. 
2.9 Quantitative polymerase chain reaction (qPCR) 
2.9.1 RNA isolation 
To isolate RNA, organoids were removed from the Matrigel™ using a 16-gauge needle 
on a 1ml syringe (Terumo, Philippines) under a dissecting microscope. Colonoids and 
spheroids were separated into 1.5 ml microcentrifuge tubes based on morphology, before being 
incubated on ice for 60 min to depolymerize the Matrigel™.  The organoids were then pelleted 
by centrifuging at 11,000 g for 5 min at 4 °C. The Matrigel™ rich supernatant was then removed 
and the RNA extracted from the colonoids and spheroids using the NucleoSpin RNA/Protein 
kit (Macherey-Nagel, Valencia, CA, USA). RNA purity was quantified using a NanoDrop 
spectrophotometer (Synergy2, BioTek, USA) in conjunction with GenEx software. Using 
nuclease-free water as a blank, 2 µl of each sample was tested in duplicate, giving the quality 





To ensure a final cDNA concentration of 20 ng/µl, isolated RNA was diluted to a 
concentration of 20 ng/µl using nuclease free water (Invitrogen, USA). A 11.5 µl aliquot of the 
isolated RNA was then added to a 1.5 ml microcentrifuge tube with 0.5 µl random hexamer 
(Invitrogen, USA) and 1 µl dNTP mix (Invitrogen, USA) and vortexed. The mixture was 
subsequently incubated in a 65 °C dry bath for 5 min, followed by a 1 min incubation on ice. 
Next, 1µl each of DTT (Invitrogen, USA), RNaseOUT™ (Invitrogen, USA) and SuperScript™ 
III RT (Invitrogen, USA) and 4 µl 5x First-Strand Buffer were added to the RNA mixture before 
being incubated in a 25 °C dry bath for 5 min. The samples were then transferred to a 50 ° C 
dry-bath for 60 min followed by a 15 min incubation in a 75 °C dry bath to deactivate the 
reaction. cDNA was either immediately used for qPCR or stored at -20 °C until required.  
2.9.3 qPCR 
All samples and housekeeping genes were run in triplicate for each treatment in each 
patient (Fig. 2.5). Human Beta-2 microglobulin (B2M) and Ribosomal Protein Lateral Stalk 
Subunit P0 (RPLP0) were used as the housekeeping genes for all qPCR experiments as it has 
previously been shown that the transcript levels of these endogenous controls are unaffected by 
the experimental treatments used (Gadeock & Butt, pers. comm., unpublished). For each gene 
a master mix containing 2.4 µl nuclease free water (see above), 5.2 µl SYBR (Takara Bio, USA) 
and 0.2 µl each of the forward, and reverse primers of the gene of interest, β2M or RPLP0 
(Integrated DNA Technologies, USA), was made for each well. 8 µl of the master mix was 
carefully pipetted into each appropriate well of a 96-well plate before being overlaid with the 
appropriate cDNA. The plate was sealed with an adhesive seal (Biorad, USA). qPCR was then 
run using a CFX connect Real-Time system (Biorad, USA). Excel was used to normalise the 





Figure 2.5: Experimental setup of a qPCR plate 
Representative image of how a sample from one experimental condition was set up in triplicate 
for qPCR experiments.  
2.10 Luciferase assay 
TOPFlash cells in conjunction with a Luciferase Assay were used to quantify the amount 
of Wnt3a and Rspo in the organoid media to ensure Wnt3a and Rspo were being sufficiently 
removed from the media and Matrigel™ over the experimental period (carried out by Dr Lisa 
Fan). TOPFlash cells express the Wnt receptors Frizzled and LRP5/6 as well as Rspo receptors 
(Ahrens et al., 2011). When these receptors become activated there is a subsequent upregulation 
of β-catenin, which translocate to the nucleus to activate the transcription factor TCF (Ahrens 
et al., 2011). TCF then translates the luciferase reporter plasmid within the genome, which 
contains TCF binding domains. This results in the translation of a fluorescent protein, which 
can then be quantified using a Luciferase Assay. 
For this experiment four wells, two containing Matrigel™ with organoids and two 
containing only Matrigel™, were used (Fig. 2.6). Organoids (and organoid free Matrigel™) 
were first maintained in 50% Wnt3a-CM + 12% Rspo-CM (normal organoid growth media, 
Table. 1) for 4 d, at which point the media was removed and stored at 4 °C. Each well was then 
washed with pre-warmed (37 °C) PBS twice for 5 min each, before being overlaid in either 0% 




media in each well was removed and stored in 4oC, before being replaced with the appropriate 
media, pre-warmed to 37 °C. 
TOPFlash cells were grown in a 24-well plate using DMEM (1X)/GlutaMAX™-1 + 1% 
Pen/strep + 10% FBS and incubated overnight at 37 °C. The cells were passaged at least once 
before being used. The next day the media collected from organoid/Matrigel™ wells over the 
experimental period were diluted (1:1) in DMEM/F12 and added to the TOPFlash cells in a 24-
well plate in triplicate. The media collected on days 4, 6, 8 and 12 were tested. A negative 
(DMEM/F12) and positive (commercial Wnt3a media, 100 ng/ml) control were also carried 
out. The TOPFlash cells were then incubated for 24 h. After incubation, the media was removed 
before the cells were washed in PBS and then lysed in 100 µl 1X lysis buffer (CCLR) at RT. 
The lysate was then transferred to a 1.5 ml microcentrifuge tube, vortexed for 15 s, then 
centrifuged at 12,000 g at 4 °C for 2 min. The supernatant was then transferred to a new 1.5 ml 
microcentrifuge tube. To carry out the luciferase assay 20 µl of the supernatant was added to a 
well of a 96-well plate. 100 µl/well of Luciferase Assay Reagent (Promega, USA) was then 
added to all wells containing cell lysate, and the luciferase activity was determined using a 
SpectraMAX® microplate reader (i3x, 560 nm, Molecular Devices, USA). Results are 





Figure 2.6: The amount of Wnt3a and Rspo remaining in Matrigel™ after washing 
To confirm Wnt3a was being adequately washed out of the organoids a luciferase assay was carried 
out. Matrigel™ containing no organoids was used as a negative control. Organoids were established 
in organoid growth media for 4 d, which was then removed, stored, and replaced with 0% Wnt3a-
CM + 0% Rspo-CM or 50% Wnt3-CM + 12% Rspo-CM, which in turn was stored and replaced 
every 2 d. The response of TOPFlash cells to Wnt and Rspo within the media, indicative of Wnt and 
Rspo concentrations, was then measured. Results demonstrate Wnt3a and Rspo were adequately 
removed from the Matrigel™ on day 4. In addition, the results suggest organoids utilise ~1/3 of the 
Wnt3a and Rspo present in organoid growth media. It is unknown why   the amount of Wnt3a and 
Rspo in the 50% Wnt3a-CM groups is increasing past day 4, although it is clearly not due to the 
production of endogenous Wnts as this is occurring in the absence of organoids. Given the purpose 
of this experiment was to confirm Wnt3a and Rspo were being adequately removed during washing 
it was decided not to investigate this finding further at this time. 
2.11 Statistical analysis  
All data was organised in Excel 2016 (Microsoft Corporation, Washington, USA) and 
entered into Prism v7.0 (GraphPad, San Diego, USA) for statistical analysis. An unpaired 
Student’s t Test was carried out for all organoid growth characterisation experiments except 
organoid survival, which was analysed using a One sample t Test against the hypothetical value 
of 100. When analysing mean diameter and relative number a One-way ANOVA with 
Dunnett’s post-hoc, or Two-way ANOVA with Dunnett’s post-hoc Test for DAPT experiments, 
was utilised to compare each treatment to the control on days 4 and 15. An unpaired Student’s 
t Test was used to compare day 4 to day 15.  Analysis of organoid survival, Ki67, alcian blue 
and MUC2 experiments was carried out using a One-Way ANOVA with Dunnett’s post-hoc 
Test, or Sidak’s post-hoc Test for DAPT experiments. qPCR data was normalised to the 




analysis was carried out using an unpaired Student’s t Test. All values are presented as mean ± 
SEM unless otherwise stated. Sample size is shown as n= the number of spheroids or colonoids 





3.1 Characterisation of organoid growth   
Current protocols for the growth of colonic organoids utilise high concentrations of 
Wnt3a in the growth media to promote the rapid proliferation of TA cells, mimicking the in 
vivo crypt base stem cell niche (Kosinski et al., 2007; Barker et al., 2008). After being passaged, 
disrupted colonic crypts first organise into spheroids: 3D structures comprised of an 
undifferentiated simple squamous epithelium (Gadeock & Butt, pers. comm., unpublished). 
However, over time the epithelial cells begin to differentiate into the simple columnar 
epithelium seen in colonoids. Previously, the colonic epithelial stem cells grown in our 
laboratory have primarily differentiated into absorptive colonocytes, with only ~2-5% 
becoming goblet cells, a vast contrast to the ~50% seen in native colonic tissue (Gersemann et 
al., 2009). Furthermore, within our laboratory the growth of organoids has been observed, but 
never quantified. Therefore, we grew organoids in 50% Wnt3a-CM for 15 d, recording the 
relative number and mean diameter of spheroids and colonoids on day 4 and 15. Organoids 
were then processed and stained for mucins, MUC2 or Ki67 using histology, fluorescent 
immunohistochemistry and chromogenic immunohistochemistry respectively.  
3.1.1 Differentiation of spheroids into colonoids 
To quantify the differentiation of spheroids into colonoids we recorded the number of 
spheroids and colonoids on day 4 and day 15, expressing the proportion of each as a percentage 
of the total number of organoids. After 11 d growth in high Wnt3a media, the relative number 
of colonoids was significantly increased (P<0.0001) from 31% ± 3.8 to 65% ± 4.0 (Fig. 3.1 
A,B,E). This result coincided with a significant decrease (P<0.0001) in spheroids from 69 ± 4.9 
to 35 % ± 4.0 over the experimental period (Fig. 3.1 A,B,D). Spheroids were occasionally 




day 4 (Fig. 3.1 C). Furthermore, merging spheroids which appeared to be undergoing 
differentiation into colonoids were observed (Fig. 3.1 C). 
 
Figure 3.1: The growth of organoids on days 4 and 15 when grown in 50% Wnt3a-CM 
Representative dissecting microscope images of organoids grown in 50% Wnt3a-CM on A) day 
4 and B-C) day 15. A) and B) are the same well. Green arrows indicate spheroids differentiating 
into colonoids. Red arrows indicate spheroids appearing to merge. The orange arrow indicates a 
merging spheroid appearing to differentiate into a colonoid. All images were taken with a Leica 
EC3 camera at A-B) 25x and C) 40x objective. Quantification of the relative number of D) 
spheroids and E) colonoids on days 4 and 15. *Significantly less spheroids, and more colonoids, 
were present on day 15 compared with day 4 (****P<0.0001, unpaired Student’s t Test). All 






3.1.2 Organoid survival 
Having quantified the differentiation of spheroids into colonoids in high Wnt3a 
conditions, next the survival of organoids over the 11 d period was investigated by expressing 
the number of organoids on day 15 as a percentage of the number of organoids on day 4. 
Associated with the growth of organoids from day 4 to day 15 was a significant reduction 
(P<0.001) in the total number of organoids, with only 62% ± 7.7 remaining on day 15 (Fig. 
3.2). Spheroids exhibited a significant reduction (P<0.0001) in relative number over the 11 d 
period, with only 31% ± 4.5 remaining on day 15 (Fig. 3.2). In contrast, colonoids showed a 





Figure 3.2: Organoid survival when grown in 50% Wnt3a-CM for 11d 
Representative dissecting microscope images of organoids from the same well grown in 50% 
Wnt3a-CM on A) day 4 and B) day 15. All images were taken with a Leica EC3 camera at 25x 
objective. C) Quantification of the relative number of spheroids, colonoids, and total organoids 
on day 15 expressed as a percentage of the number on day 4. *Significantly more colonoids 
and less spheroids and total organoids were present on day 15 (*P<0.05, ***P<0.001, 
****P<0.0001, One sample t Test comparing the mean values to the hypothetical value of 
100). All values are mean ± SEM, N=11. 
3.1.3 Organoid size 
Another important aspect of organoid growth is their final size, which is indicative of 
their proliferative capacity. When grown in high Wnt3a media, spheroids exhibited a significant 
increase (P<0.01) in mean diameter from 296 µm ± 7 on day 4 to 380 µm ± 14 on day 15 (Fig. 
3.3 A-C). Similarly, colonoids were significantly larger on day 15 (505 µm ± 18, P<0.001) 





Figure 3.3: The mean diameter of organoids on days 4 and 15 when grown in 50% Wnt3a-
CM 
Representative dissecting microscope images of organoids from the same well grown in 50% 
Wnt3a-CM on A) day 4 and B) day 15. All images were taken with a Leica EC3 camera at 25x 
objective. Quantification of the mean diameter of C) spheroids and D) colonoids on day 4 and 15. 
There was a significant increase in the mean diameter of spheroids, and colonoids, on day 15 
compared with day 4 (**P<0.01, ***P<0.001, unpaired Student’s t Test). All values are mean ± 
SEM, N=11, n=417 day 4 spheroids, n=149 day 15 spheroids, n=186 day 4 colonoids, n=239 day 
15 colonoids. 
3.1.4 Organoid proliferation 
Ki67 is a nuclear protein that is expressed during cellular division and is therefore a strong 
indicator of cellular proliferation (Scholzen & Gerdes, 2000). Ki67 immunoreactivity in the 
nucleus was utilised to quantify proliferating cells in colonoids and spheroids. The number of 
Ki67 positive nuclei in each organoid was expressed as a percentage of the total number of 
cells. There were significantly more Ki67 positive nuclei in spheroids (22% ± 4, P<0.05, Fig. 





Figure 3.4: Proportion of Ki67 positive nuclei on day 15 colonoids and spheroids grown in 50% 
Wnt3a-CM  
Representative images of a A) spheroid and B) colonoid from the same patient stained for Ki67 after 
being grown in 50% Wnt3a-CM for 15 d. Brown nuclei are Ki67 positive whereas blue nuclei are 
Ki67 negative. Arrows indicate Ki67 positive nuclei. Images were taken at 40x objective and 21.6x 
objective for the spheroid and colonoid respectively. C) Quantification of the percentage of Ki67 
positive nuclei in spheroids and colonoids. *Significantly more Ki67 positive nuclei were present in 
spheroids compared with colonoids (*P<0.05, unpaired Student’s t Test). All values are mean ± SEM, 
N=11, n=49 spheroids, n=167 colonoids. 
3.1.5 Goblet cell expression in organoids 
For colonic organoids to be representative of the colonic epithelium, it is important that 
the proportion of the different mature epithelial cell types are consistent with the native tissue. 
Using histology and immunofluorescence, our laboratory has previously shown colonic 
organoids grown in high Wnt3a media express ~2-5% goblet cells (Gadeock & Butt, pers. 




To confirm our previous findings, organoids were grown in 50% Wnt3a-CM for 15 d and 
stained either with alcian blue or MUC2 immunofluorescence. Alcian blue positive and MUC2 
positive cells in each colonoid were counted and expressed as a percentage of the total number 
of cells. As seen previously, the number of alcian blue positive and MUC2 positive cells was 
below 5%, consistent with previous findings in our laboratory (Fig. 3.5 A,C-D). There was no 
significant difference between the relative number of alcian blue positive cells (3% ± 0.4, Fig. 
3.5 C-D) and MUC2 positive cells (3% ± 0.4, Fig. 3.5 A,C) in colonoids on day 15.  
Two primary morphologies of alcian blue positive cells were observed in colonoids. Most 
cells stained with alcian blue were columnar, with dense apical staining of mucins and a lack 
of basal nuclei (Fig. 3.5 C). In contrast, a small proportion of alcian blue positive cells had a 
goblet morphology, with perinuclear and cytoplasmic mucins, which was denser in the apical 
region (Fig. 3.5 C). These cells also exhibited basal nuclei, which were more compressed 
compared with neighbouring epithelial cells (Fig. 3.5 C). This morphology is characteristic of 
goblet cells found in vivo (Cheng & Leblond, 1974; Karam, 1999). A majority of MUC2 
positive nuclei exhibited a goblet cell-like phenotype, showing perinuclear MUC2 that 
extended into the apical compartment (Fig. 3.5 B). The intensity of MUC2 staining in these 
cells would range from low (Fig. 3.5 A) to high (Fig. 3.5 B), with low staining intensity being 
more commonly observed. Unlike goblet cells found in vivo, the nuclei of MUC2 positive cells 
did not often appear basal, at times extending to near the apical compartment (Fig. 3.5 A-B). 
Although not quantified, goblet cells were often observed co-localising to specific regions of 





Figure 3.5: Proportion of goblet cells on colonoids grown in 50% Wnt3a-CM on day 15 
Representative A and B) fluorescent microscope and C) scanned images of colonoids from the same 
patient stained with alcian blue or for MUC2 after being grown in 50% Wnt3a-CM for 15 d. A and 
B) MUC2 positive cells have green cytoplasm and blue nuclei whereas C) alcian blue positive cells 
have blue cytoplasm and pink nuclei. Red arrow indicates alcian blue positive cell with a goblet cell 
morphology, black arrows indicate alcian blue positive cells with abnormal morphology and white 
arrows indicate MUC2 positive cells. Images taken at A) 20x and B) 100x objective using an 
Olympus BX51 and C) 40x objective. D) Quantification of the proportion of alcian blue positive, 
and MUC2 positive cells in colonoids. There was no statistically significant difference between the 
two groups (unpaired Student’s t Test). All values are mean ± SEM, N=11, n=120 MUC2 positive 




3.2 Experiment 1: Reduced Wnt3a conditioned media  
Colonic organoids grown in a high Wnt3a media have a marked reduction in goblet cell 
expression compared with the native tissue. This may be due to high Wnt3a signalling 
promoting a decrease in ATOH1 via GSK3β mediated degradation, in conjunction with an 
increase in HES1 via TCF/LEF targeting of the HES1 promotor (Aragaki et al., 2008; Rodilla 
et al., 2009; Peignon et al., 2011). In the colon, high HES1 is associated with differentiation 
into the absorptive lineage, while high ATOH1 promotes differentiation into the secretory 
lineage (Yang et al., 2001; Shroyer et al., 2007). Therefore, organoids were grown in media 
containing reduced concentrations of Wnt3a-CM (0, 5, 10, 25 and 50%) to identify any changes 
in goblet cell expression, cellular proliferation and organoid growth. 
3.2.1 Effect of reduced Wnt3a-CM on organoid differentiation  
The canonical Wnt signalling pathway, of which Wnt3a is a critical activator, regulates 
differentiation of intestinal epithelial stem cells (Fevr et al., 2007). We therefore hypothesised 
a reduction in Wnt3a would increase the differentiation of spheroids to colonoids. 
Unexpectedly, in reduced Wnt3a-CM there was no significant difference in the relative number 
of colonoids, or spheroids, on day 15 compared with the control (Fig. 3.6). There were 
significantly less spheroids (P<0.01, P<0.001) on day 15 compared with day 4, whereas 
colonoids exhibited a significant increase (P<0.01, P<0.001) in relative number over the 
experimental period (Fig. 3.6). Unsurprisingly, no significant difference in the relative number 






Figure 3.6: Effect of reduced Wnt3a on the relative number of organoids on days 4 and 15  
Representative dissecting microscope images of A and C) day 4 and B and D) day 15 organoids from 
the same well grown in A-B) 0% Wnt3a-CM or C-D) 50% Wnt3a-CM for 11 d. All images were 
taken with a Leica EC3 camera at 25x objective. C-D) is the same control as seen in Fig. 3.2. 
Quantification of the relative number of E) spheroids and F) colonoids grown in experimental and 
control conditions. *Significantly less spheroids, and more colonoids were present on day 15 
compared with day 4 (**P<0.01, ***P<0.001, One-way ANOVA with Dunnett’s post-hoc Test). 
Reduced Wnt3a-CM had no effect on the number of spheroids or colonoids on days 4 or 15 (One-






3.2.2 Effect of reduced Wnt3a-CM on organoid survival  
Having shown Wnt3a has no effect on the differentiation of spheroids to colonoids, the 
effect of reduced Wnt3a on organoid survival was investigated as previously described. The 
withdrawal of Wnt in vivo results in a significant loss of intestinal epithelial stem cells, which 
differentiate into absorptive cells (Fevr et al., 2007). It was therefore expected that as the 
concentration of Wnt3a decreased organoid growth would be altered. Surprisingly reduced 
Wnt3a had no significant effect on the relative number of spheroids, colonoids or total 
organoids on day 15, even when Wnt3a was completely withdrawn (Fig. 3.7). Consistent with 
previous findings, the total number of organoids dropped on average 53% ± 12.1 over the 11 d 
period (Fig. 3.7 A-D,C). In addition, on day 15 there were more colonoids than on day 4 (Fig. 





Figure 3.7: Effect of reduced Wnt3a-CM on the proportion of remaining organoids on day 15 
Representative dissecting microscope images of organoids on A and C) day 4 and B and D) day 15 
grown in A-B) 0% Wnt3a-CM and C-D) 50% Wnt3a-CM for 11 d. All images were taken with a 
Leica EC3 camera at 25x objective. C-D) is the same control as seen in Fig. 3.2. Quantification of the 
proportion of E) total organoids, F) spheroids and G) colonoids remaining on day 15 as a percentage 
of the proportion on day 4. Reduced Wnt3a had no effect on the survival or spheroids, colonoids, or 
total organoids over the 11 d period (A One-way ANOVA with Dunnett’s post-hoc Test). All values 




3.2.3 Effect of reduced Wnt3a-CM on organoid size 
The canonical Wnt pathway is a key driver of stem cell proliferation in the colonic crypt 
base (Kuhnert et al., 2004; Fevr et al., 2007). We therefore hypothesised that as Wnt3a was 
reduced, the mean diameter of spheroids and colonoids would decrease as a result of decreased 
proliferation. On day 15, colonoids grown in 0% Wnt3a-CM (424 µm ± 18.6, P<0.05), 5% 
Wnt3a-CM (451 µm ± 18.2, P<0.01) and 10% Wnt3a-CM (429 µm ± 17.3, P<0.05) had a 
significantly smaller mean diameter compared with the control (543 µm ± 36.7) (Fig. 3.8 
B,D,F). Interestingly, reduced Wnt3a-CM had no effect on the mean diameter of spheroids on 
day 15 when compared with the control (Fig. 3.8 B,D,E). When compared with day four, 
colonoids grown in experimental and control conditions had a significantly larger mean 
diameter on day 15 (P<0.01, P<0.001) (Fig. 3.8 A-D,F). In contrast, only spheroids grown in 
10% Wnt3a-CM (P<0.05) and 50% Wnt3a-CM (P<0.05) had significantly increased mean 
diameters on day 15 compared with day 4 (Fig. 3.8 A-D,E). Expectedly Wnt3a had no 
significant effect on the mean diameter of spheroids, or colonoids on day 4 (One-way ANOVA 





Figure 3.8: Effect of reduced Wnt3a-CM on the mean diameter of organoids on days 4 and 15 
Representative dissecting microscope images of A and C) day 4 and B and D) day 15 organoids grown 
in A-B) 0% Wnt3a-CM or C-D) 50% Wnt3a-CM for 11 d All images were taken with a Leica EC3 
camera at 25x objective. C-D) is the same control as seen in Fig. 3.2. Quantification of the mean 
diameter of E) spheroids and F) colonoids grown in experimental and control conditions. 
*Significantly larger colonoids were present on day 15, compared with day 4 in all experimental 
conditions (**P<0.01, ****P<0.0001 One-way ANOVA with Dunnett’s post-hoc Test). In contrast 
day 15 spheroids were significantly larger than on day 4 when grown in 10% Wnt3a-CM and 50% 
Wnt3a-CM (*P<0.05, One-way ANOVA with Dunnett’s post-hoc Test). Colonoids grown in 0% 
Wnt3a-CM, 5% Wnt3a-CM and 10% Wnt3a-CM had significantly smaller mean diameters on day 15 
compared with the control (*P<0.05, **P<0.01, One-way ANOVA with Dunnett’s post-hoc Test). 
All values are mean ± SEM, N=3, n=19-320 day 4 spheroids, n=18-41 day 15 spheroids, n=38-45 day 






3.2.4 Effect of reduced Wnt3a-CM on organoid proliferation 
Although the size of organoids can be indicative of proliferative capacity, the gold 
standard is Ki67, a nuclear marker of cellular proliferation (Scholzen & Gerdes, 2000). As 
mentioned, Wnt3a signals through the canonical Wnt signalling pathway to directly regulate 
stem cell proliferation in the colon (Kuhnert et al., 2004; Fevr et al., 2007). Therefore, we 
expected to observe a reduction in Ki67 staining as Wnt3a concentration decreased. We also 
expected to see an increase in Ki67 staining in spheroids compared with colonoids, as shown 
previously (Fig. 3.4). Reduced Wnt3a was found to have no significant effect on the proportion 
of Ki67 positive nuclei in both spheroids and colonoids (Fig. 3.9). A significant difference in 
the percentage of Ki67 positive nuclei between spheroids and colonoids was only observed 
when grown in 10% Wnt3a-CM (P<0.0001, One-way ANOVA with Dunnett’s post-hoc Test, 
Supplementary. 6.1) and 50% Wnt3a-CM (P<0.001, One-way ANOVA with Dunnett’s post-
hoc Test, Supplementary. 6.1). It is important to note that, except for the 0% Wnt-CM group, 
the mean percentage of Ki67 positive nuclei in spheroids was at least 20% higher compared 
with colonoids in each experimental group (Fig. 3.9 C-D). This may be a result of the low 





Figure 3.9: Effect of reduced Wnt3a-CM on the proportion of Ki67 positive nuclei in organoids 
on day 15 
Representative scanned images of A-B) colonoids from the same patient stained for Ki67 after being 
grown in A) 0% Wnt3a-CM and B) 50% Wnt3a-CM for 11 d. Ki67 positive nuclei are brown, while 
Ki67 negative nuclei are blue. Arrows indicate Ki67 positive nuclei. Images taken at A) 34x B) 20x 
objective. B) is the same control as seen in Fig. 3.4.  Quantification of the percentage of Ki67 positive 
nuclei in C) spheroids and D) colonoids grown in experimental and control conditions. Reduced 
Wnt3a had no significant effect on the percentage of Ki67 positive nuclei in spheroids or colonoids 
(One-way ANOVA with Dunnett’s post-hoc Test). All values are mean ± SEM, N=3, n=3-6 






3.2.5 Effect of reduced Wnt3a-CM on alcian blue positive cell 
expression  
To investigate our hypothesis that high Wnt3a signalling was suppressing goblet cell 
differentiation in colonic epithelial stem cells, organoids were stained with alcian blue to 
visualise acid mucins within cells. Alcian blue positive cells in each colonoid were counted and 
expressed as a percentage of the total number of cells. Interestingly, reduced Wnt3a-CM had 
no significant effect on the number of alcian blue positive cells in colonoids on day 15, which 
was no higher than 4.4% ± 0.8 (Fig. 3.10). As seen previously, two distinct morphologies of 
alcian blue positive cells were present, with the abnormal morphology being the predominant 





Figure 3.10: Effect of reduced Wnt3a-CM on the percentage of alcian blue positive cells 
in colonoids on day 15 
Representative scanned images of colonoids from the same patient stained with alcian blue 
after being grown in A) 0% Wnt3a-CM and B) 50% Wnt3a-CM for 11 d. Alcian blue positive 
cells have a blue cytoplasm with pink nuclei, while alcian blue negative cells have pink nuclei. 
Red arrows indicate alcian blue positive cells with a goblet cell-like morphology, whereas 
black arrows indicate alcian blue positive cells with abnormal goblet cell morphology. Images 
taken at A) 20x and B) 40x objective. B) is the same control as seen in Fig. 3.5. C) 
Quantification of the percentage of alcian blue positive cells in colonoids grown in 
experimental and control conditions. Reduced Wnt3a had no significant effect on the 
percentage of alcian blue positive cells in colonoids (One-way ANOVA with Dunnett’s post-






3.2.6 Effect of reduced Wnt3a-CM on MUC2 positive cell expression  
While alcian blue can be a powerful tool for the identification of goblet cells, it is a non-
specific method which stains secreted, and membrane bound mucins, and therefore cannot 
discriminate between MUC2 and other mucins. MUC2 is the predominant secretory mucin 
found in the colon and is a classic marker for intestinal goblet cells (Johansson et al., 2011). In 
order to confirm our previous result, we used immunofluorescence staining of MUC2 to 
quantify the expression of goblet cells. The number of MUC2 positive cells in each colonoid 
was expressed as a percentage of the total number of cells. Confirming our alcian blue data, 
reduced Wnt3a had no significant effect on the percentage of MUC2 positive cells in colonoids 
on day 15 compared with the control (Fig. 3.11). MUC2 cell morphology was consistent with 





Figure 3.11: Effect of reduced Wnt3a-CM on the proportion of MUC2 positive cells in 
colonoids on day 15 
Representative scanned images of colonoids from the same patient stained for MUC2 after being 
grown in A) 0% Wnt3a-CM and B) 50% Wnt3a-CM for 11 d. MUC2 positive cells have a green 
cytoplasm with blue nuclei, whereas MUC2 negative cells contain blue nuclei only. Arrows indicate 
MUC2 positive cells. Images taken with an Olympus BX51 camera at 20x objective. B) is the same 
control as seen in Fig. 3.5. C) Quantification of the percentage of MUC2 positive cells in colonoids 
grown in experimental and control conditions. Reduced Wnt3a had no significant effect on the 
percentage of MUC2 positive cells in colonoids (One-way ANOVA with Dunnett’s post-hoc Test). 




3.3 Experiment 2: Withdrawn Wnt3a-CM + reduced Rspo-CM 
When grown in media containing reduced concentrations of Wnt3a colonoids exhibited 
no significant change in proliferation or goblet cell expression. This result was surprising given 
the importance of canonical Wnt signalling in the maintenance of colonic epithelial stem cell 
proliferation, and its role in lineage specification (Fevr et al., 2007; Aragaki et al., 2008; Rodilla 
et al., 2009; Peignon et al., 2011). One explanation is Wnt3a was not being adequately washed 
out of the Matrigel™ on day 4, however a luciferase assay of TOPFlash cells demonstrated this 
was not the case (Refer to section 2.10, Fig. 2.6). Another possibility is endogenous epithelial 
Wnts were being produced by colonoids. Although the luciferase assay showed no increase in 
Wnts over the experimental period in either 0% Wnt3a-CM + 0% Rspo-CM or 50% Wnt3a-
CM + 12% Rspo-CM, recent evidence suggests Wnts can travel from the source cell in a cell-
bound manner via cellular division, as opposed to through diffusion (Farin et al., 2016). To 
confirm endogenous epithelial Wnts were compensating for the loss of Wnt3a organoids were 
grown in reduced Rspo, in the absence of Wnt3a. Rspondins potently potentiate Wnt signalling 
and are a critical component of organoid growth media. When the Rspo receptors Lgr4/5 were 
inducibly knocked out in murine small intestinal organoids, death of the culture quickly 
followed (de Lau et al., 2011). Established organoids (grown in organoid growth media) were 
grown in media containing either 0% Wnt3a-CM + 12% Rspo-CM, 0% Wnt3a-CM + 0% Rspo-
CM, 0% Wnt3a-CM + 3% Rspo-CM or 50% Wnt3a-CM + 12% Rspo-CM, and any changes in 





3.3.1 Effect of 0% Wnt3a-CM + reduced Rspo-CM on organoid 
differentiation 
We next investigated the effect of reduced Rspo on the differentiation of spheroids to 
colonoids as described previously. On day 4, there was no difference in the relative number of 
spheroids, or colonoids, across all experimental groups (Fig. 3.12 A,C,E-F). Similarly, no 
difference in colonoid or spheroid number was observed between the groups on day 15 (Fig. 
3.12 B,D,E-F). As seen previously, there was a significant decrease in spheroids (P<0.01, 
P<0.001, Fig. 3.12 A-D,E), and significant increase in colonoids (P<0.01, P<0.001, Fig. 3.12 
A-D,F) over the experimental period. Organoids grown in 0% Wnt3a + reduced Rspo had no 
statistically significant effect on the relative number of spheroids, or colonoids, on days 4 or 15 
(Fig. 3.12). Despite this, colonoids grown in a combination of 0% Wnt3a and reduced Rspo 
were generally flatter and lined the bottom of the well (Fig. 3.12 B and Fig. 3.14 B). This 
phenotype was not observed in the 0% Wnt3a-CM + 12% Rspo-CM or 50% Wnt3a-CM + 12% 





Figure 3.12: Effect of 0% Wnt3a-CM + reduced Rspo-CM on the relative number of organoids 
on days 4 and 15 
Representative dissecting microscope images of organoids on A and C) day 4 and B and D) day 15, 
grown in either A-B) 0% Wnt3a-CM + 3% Rspo-CM or C-D) 50% Wnt3a-CM + 12% Rspo-CM for 
11 d. Images taken with a Leica RC3 camera at 25x objective. C-D) is the same control as seen in 
Fig. 3.1 and Fig. 3.3. Quantification of the relative number of E) spheroids and F) colonoids on days 
4 and 15. *Significantly more colonoids, and less spheroids, were present on day 15 compared with 
day 4 (**P<0.01, ***P<0.001, One-way ANOVA with Dunnett’s post-hoc Test). There was no 
significant effect of 0% Wnt3a + reduced Rspo on the relative number of organoids on days 4 and 15 






3.3.2 Effect of 0% Wnt3a-CM + reduced Rspo-CM on organoid 
survival   
Having determined the differentiation of spheroids to colonoids is unaffected by Rspo, 
the effect of reduced Rspo concentrations on organoid survival were investigated. Withdrawal 
of Wnt3a in conjunction with reduced Rspo had no significant effect on the survival of 






Figure 3.13: Effect of 0% Wnt3a-CM + reduced Rspo-CM on the proportion of remaining 
organoids on day 15 
Representative dissecting microscope images of organoids on A and C) day 4 and B and D) day 15, 
grown in either A-B) 0% Wnt3a-CM + 3% Rspo-CM or C-D) 50% Wnt3a-CM + 12% Rspo-CM for 
11 d. Images taken with a Leica RC3 camera at 25x objective. C-D) is the same control as seen in 
Fig. 3.1 and Fig. 3.3. Quantification of the number of E) total organoids, F) spheroids and G) 
colonoids on day 15, expressed as a percentage of the number on day 4. There was no significant 
effect of 0% Wnt3a or reduced Rspo on the proportion of spheroids, colonoids or total organoids 






3.3.3 Effect of 0% Wnt3a-CM + reduced Rspo-CM on organoid size 
When grown in media containing no Wnt3a, the mean diameter of spheroids and 
colonoids was unchanged compared with organoids grown in control conditions, a surprising 
result given the importance of Wnt signalling in regulating stem cell proliferation. To determine 
whether this was a result of Rspo amplifying endogenous epithelial Wnts, we measured the day 
4 and day 15 mean diameter of organoids grown in 0% Wnt3a-CM + reduced Rspo-CM. 
Colonoids exhibited a significant increase in mean diameter (P<0.0001) on day 15, compared 
with day 4 across all experimental conditions (Fig. 3.14 A-D,F). Only the 0% Wnt3a-CM + 0% 
Rspo-CM and the 50% Wnt3a-CM + 12% Rspo-CM groups exhibited a significant increase 
(P<0.05, P<0.001) in spheroids over the experimental period (Fig. 3.14 A-D,E). In addition, the 
growth of organoids in 0% Wnt3-CM + reduced Rspo-CM has no significant effect on the mean 





Figure 3.14: Effect of 0% Wnt3a-CM + reduced Rspo-CM on the mean diameter of organoids 
on days 4 and 15 
Representative dissecting microscope images of organoids on A and C) day 4 and B and D) day 15, 
grown in either A-B) 0% Wnt3a-CM + 0% Rspo-CM or C-D) 50% Wnt3a-CM + 12% Rspo-CM for 
11 d. Images taken with a Leica RC3 camera at 25x objective. C-D) is the same control as seen in 
Fig. 3.1 and Fig. 3.3.  Quantification of the mean diameter of E) spheroids and F) colonoids on days 
4 and 15. *Significantly larger colonoids were present on day 15 compared with day 4 
(****P<0.0001, One-way ANOVA with Dunnett’s post-hoc Test). Spheroids were significantly 
larger on day 15 compared with day 4 when grown in 0% Wnt3a-CM + 0% Rspo-CM and 50% 
Wnt3a-CM + 12% Rspo-CM (*P<0.05, ***P<0.001, One-way ANOVA with Dunnett’s post-hoc 
Test). Withdrawal of Wnt3a + reduced Rspo had no significant effect on the mean diameter of 
spheroids, or colonoids, on days 4 and 15 (One-way ANOVA with Dunnett’s post-hoc Test). All 
values are mean ± SEM, N=3, n=134-161 day 4 spheroids, n=24-54 day 15 spheroids, n=50-102 day 






3.3.4 Effect of 0% Wnt3a-CM + reduced Rspo-CM on organoid 
proliferation 
To determine whether the removal of Wnt3a and Rspo influenced organoid proliferation, 
immunohistochemistry against Ki67 was utilised to quantify the proportion of proliferating 
nuclei. Consistent with our size results, there was no significant increase in the number of Ki67 
positive nuclei in colonoids, or spheroids, grown in 0% Wnt3a-CM + 12% Rspo-CM, 0% 
Wnt3a-CM + 3% Rspo-CM and 50% Wnt3a-CM + 12% Rspo-CM (Fig. 3.15 B-C,E-F,G-H). 
Interestingly, there were significantly less Ki67 positive nuclei (P<0.01) in colonoids, but not 
spheroids, grown in the absence of Wnt3a and Rspo (Fig. 3.15 A,D,G-H). The percentage of 
Ki67 positive nuclei was not significantly different between spheroids and colonoids (unpaired 





Figure 3.15: Effect of 0% Wnt3a-CM + reduced Rspo-CM on the proportion of Ki67 positive 
nuclei in organoids on days 4 and 15 
Representative scanned images of  A-C) spheroids and D-F) colonoids from the same patient stained 
for Ki67 after being grown in either A and D) 0% Wnt3a-CM + 0% Rspo-CM, B and E) 0% Wnt3a-
CM + 3% Rspo-CM or C and F) 50% Wnt3a-CM + 12% Rspo-CM, for 11 d. Ki67 positive nuclei 
are brown, while Ki67 negative nuclei are blue. Arrows indicate Ki67 positive nuclei. Images taken 
at the following objectives A) 27x B) 40x C) 40x D) 30x E) 27x F) 21x. Quantification of the 
percentage of proliferating cells within G) spheroids and H) colonoids on day 15. *Significantly less 
Ki67 positive nuclei were present in colonoids on day 15 compared with the control when grown in 
the absence of Wnt3a and Rspo (**P<0.01, One-way ANOVA with Dunnett’s post-hoc Test). All 




3.3.5 Effect of 0% Wnt3a-CM + reduced Rspo-CM on alcian blue 
positive cell expression 
The removal of Wnt3a had no effect on the expression of alcian blue positive cells in 
colonoids. To confirm this result colonoids grown in 0% Wnt3a-CM + reduced Rspo-CM were 
stained with alcian blue to quantify mucin positive cells. Unexpectedly colonoids grown in 0% 
Wnt3a-CM + 12% Rspo-CM had significantly more alcian blue positive cells (11% ± 3.6, 
P<0.0001, Fig. 3.16 C) compared with the control (2% ± 0.4, Fig. 3.16 B-C), contradicting 
previous findings. Alcian blue positive cells in colonoids grown in 0% Wnt3a-CM + 0% Rspo-
CM or 0% Wnt3a-CM + 3% Rspo-CM were not significantly different compared with the 





Figure 3.16: Effect of 0% Wnt3a-CM + reduced Rspo-CM on the proportion of alcian blue 
positive cells in colonoids on day 15 
Representative scanned images of colonoids from the same patient stained with alcian blue after 
being grown in either A) 0% Wnt3a-CM + 0% Rspo-CM B) 50% Wnt3a-CM + 12% Rspo-CM 
for 11 d. Alcian blue positive cells have a blue cytoplasm with pink nuclei, while alcian blue 
negative cells only contain pink nuclei. Red arrows indicate alcian blue positive cells with a goblet 
cell-like morphology, whereas black arrows indicate alcian blue positive cells with abnormal 
goblet cell morphology. Images were taken at the following A) 19x and B) 15x objective. C) 
Quantification of the percentage of alcian blue positive cells in colonoids on day 15. *Significantly 
more alcian blue positive cells were present in colonoids grown in 0% Wnt3a-CM + 12% Rspo-
CM (****P<0.0001, One-way ANOVA with Dunnett’s post-hoc Test). All values are mean ± 






3.3.6 Effect of 0% Wnt3a-CM + reduced Rspo-CM on MUC2 positive 
cell expression 
To confirm withdrawal of Wnt3a + normal Rspo concentrations increase goblet 
expression of goblet cells in colonoids, MUC2 in organoids was stained using 
immunofluorescence as described previously. There were significantly more MUC2 positive 
cells in all experimental conditions (P<0.001, P<0.0001, Fig. 3.17). An increase in MUC2 
positive cells in colonoids grown in 0% Wnt3a-CM + 12% Rspo-CM contradicts our previous 
MUC2 findings (Fig. 3.11) but supports our previous alcian blue data (Fig. 3.10). Both distinct 





Figure 3.17: Effect of 0% Wnt3a-CM + reduced Rspo-CM on the proportion of MUC2 positive 
cells in colonoids on day 15 
Representative scanned images of colonoids from the same patient stained for MUC2 after being 
grown in A) 0% Wnt3a-CM + 12% Rspo-CM and B) 50% Wnt3a-CM + 12% Rspo-CM for 11 d. 
MUC2 positive cells have a green cytoplasm with blue nuclei, whereas MUC2 negative cells contain 
blue nuclei only. Arrows indicate MUC2 positive cells. Images taken with an Olympus BX51 at 20x 
objective. C) Quantification of the percentage of MUC2 positive cells in colonoids on day 15. 
*Significantly more MUC2 positive cells were present in colonoids grown in 0% Wnt3a-CM + 
reduced and normal Rspo (***P<0.001, ****P<0.0001, One-way ANOVA with Dunnett’s post-hoc 





3.4 Experiment 3: Reduced Wnt3a-CM ± DAPT 
Previously our laboratory has shown that organoids grown in control conditions have high 
HES1, but low ATOH1 expression (Fan & Butt pers. comm., unpublished). Interestingly, when 
Notch signalling was inhibited using DAPT, a Notch inhibitor, in high Wnt3a media, HES1 
expression was unchanged. Moreover, the addition of DAPT had no effect on the proportion of 
goblet cells, which remained at ~2-5%. We hypothesised this was due to the high Wnt3a 
conditions promoting an increase in HES1 expression through TCF/LEF interaction with the 
HES1 promotor, resulting in increased differentiation into the absorptive lineage at the expense 
of differentiation into the secretory lineage. We grew organoids in 5% Wnt3a-CM ± DAPT, 
10% Wnt3a-CM ± DAPT or 50% Wnt3a-CM ± DAPT for 11 d to elucidate the effect Notch 
inhibition has on goblet cell and MUC2 expression, cellular proliferation and organoid growth 
at reduced levels of Wnt3a.  
3.4.1 Effect of reduced Wnt3a-CM ± DAPT on organoid differentiation 
Like Wnt, Notch helps to regulate the differentiation of intestinal epithelial stem cells to 
mature epithelial cells (VanDussen et al., 2012). We therefore hypothesised DAPT would alter 
the differentiation of spheroids into colonoids. To test this hypothesis the proportion of 
spheroids and colonoids grown in reduced Wnt3a-CM ± DAPT was recorded as described 
previously. There was a significant reduction in the relative number of spheroids (P<0.01, Fig. 
3.18 A-B,E), and an increase in the relative number of colonoids (P<0.01, Fig. 3.18 A-B,F) 
when grown in 5% Wnt3a-CM + DAPT, compared with organoids grown in 5% Wnt3a-CM. 
There was a significant decrease in the relative number of spheroids (P<0.01, P<0.0001, One-
way ANOVA with Sidak’s post-hoc Test, Supplementary. 6.3), and an increase in the relative 
number of colonoids (P<0.01, P<0.0001, Supplementary. 6.3), on day 15 compared with day 4 




the relative number of spheroids or colonoids on day 4 (One-way ANOVA with Sidak’s post-
hoc Test, Supplementary. 6.3) in the presence, or absence, of DAPT.  
Colonoids grown in the presence of DAPT appeared to organise inside out 10-40% more 
often compared with non DAPT treated colonoids, although more in depth analysis is required. 
An inside out organoid was identified as having a continuous glycocalyx on the outside (Fig. 
3.22 B). 
 
Figure 3.18: Effect of reduced Wnt3a-CM ± DAPT on the relative number of organoids on 
day 15 
Representative images of day 15 organoids grown in A-B) 5% Wnt3a-CM and C-D) 50% Wnt3a-
CM either in the A and C) absence or B and D) presence of DAPT for 11 d. All images were taken 
with a Leica EC3 camera at 25x objective. Quantification of E) spheroids and F) colonoids grown 
in experimental and control conditions expressed as a percentage of the total number of organoids 
on day 15. *Significantly less spheroids, and more colonoids were present on day 15 when grown 
in 5% Wnt3a-CM + DAPT, compared with organoids grown in 5% Wnt3a-CM (**P<0.01, One-





3.4.2 Effect of reduced Wnt3a-CM ± DAPT on organoid survival 
We next investigated whether the addition of DAPT had any effect on organoid survival 
as described previously. As expected, there was a reduction in the total number of organoids on 
day 15, although this loss was not as marked as previously seen, ranging from 61% ± 6 to 79% 
± 14 (Fig. 1.19 A-C). As seen previously, there was a loss of around half of the spheroids over 
the experimental period (Fig. 3.19 A-B,D), coinciding with an increase in the number of 
colonoids (Fig. 3.19 A-B,E). DAPT had no significant effect on the proportion of remaining 
spheroids, colonoids or total organoids on day 15 (Fig. 3.19). Likewise, reduced concentrations 
of Wnt3a had no significant effect on the proportion of spheroids, colonoids, or total organoids 
on days 4 (One-way ANOVA with Sidak’s post-hoc Test, Supplementary. 6.3) or 15 (Fig. 3.19), 





Figure 3.19: Effect of reduced Wnt3a-CM ± DAPT on the proportion of remaining organoids 
on day 15 
Representative dissecting microscope images of organoids on A) day 4 and B) day 15 grown in 50% 
Wnt3a-CM in either the A and C) absence or B and D) presence of DAPT for 11 d. All images were 
taken with a Leica EC3 camera at 25x objective. Quantification of the effect of reduced Wnt3a ± 
DAPT on survival of C) total organoids D) spheroids and E) colonoids. DAPT had no effect on the 
survival of spheroids, colonoids, or total organoids over the experimental period (One-way ANOVA 
with Sidak’s post-hoc Test). Wnt3a had no effect on the survival or spheroids, colonoids, or total 
organoids either, in the presence, or absence, of DAPT (One-way ANOVA with Sidak’s post-hoc 





3.4.3 Effect of reduced Wnt3a-CM ± DAPT on organoid size 
In conjunction with the canonical Wnt pathway, the Notch pathway is critically involved 
in colonic epithelial stem cell proliferation (VanDussen et al., 2012). Therefore, DAPT 
mediated inhibition of Notch signalling in organoids was expected to decrease the mean 
diameter of both spheroids and colonoids. The addition of DAPT resulted in a significant 
reduction in spheroids and colonoids grown in all experimental conditions (P<0.05, P<0.0001, 
Fig. 3.20). Spheroids and colonoids were significantly smaller (P<0.05, P<0.001, P<0.0001, 
One-way ANOVA with Sidak’s post-hoc Test, Supplementary. 6.4) on day 15 compared with 
day 4 when grown in the presence of DAPT. DAPT had no effect on the mean diameter of 
colonoids on day 15 compared with day 4 (One-way ANOVA with Sidak’s post-hoc Test, 
Supplementary. 6.4). Reduced Wnt3a had no effect on the mean diameter of spheroids or 
colonoids on days 4 (One-way ANOVA with Sidak’s post-hoc Test, Supplementary. 6.4) and 





Figure 3.20: Effect of reduced Wnt3a-CM ± DAPT on the mean diameter of organoids on day 
15 
Representative dissecting microscope images of organoids grown in A-B) 5% Wnt3a-CM or C-D) 
50% Wnt3a-CM either in the A and C) absence or B and D) presence of DAPT for 11 d. All images 
were taken with a camera at 25x objective. Quantification of the effect of reduced Wnt3a ± DAPT on 
the mean diameter of E) spheroids and F) colonoids. *Significantly smaller spheroids and colonoids 
were present on day 15 when grown in the presence of DAPT (*P<0.05, ****P<0.0001, One-way 
ANOVA with Sidak’s post-hoc Test). All values are mean ± SEM, N=3, n=205-289 day 4 spheroids, 






3.4.4 Effect of reduced Wnt3a-CM ± DAPT on organoid proliferation  
When Notch signalling was inhibited using DAPT, colonoids and spheroids had 
significantly decreased mean diameters. While size can be a useful indicator for the proliferative 
capacity of organoids, the best way to quantify cellular proliferation is using the proliferation 
marker Ki67. To confirm DAPT decreases proliferation organoids were grown in reduced 
Wnt3a-CM ± DAPT for 11 d before using immunohistochemistry against Ki67 to quantify 
actively dividing cells as described previously. When treated with DAPT, no significant change 
in the percentage of Ki67 positive nuclei was observed in spheroids (Fig. 3.21 A,D,E). 
Interestingly, DAPT treatment significantly decreased the percentage of Ki67 positive nuclei in 
colonoids grown in 10% Wnt3a-CM (P<0.01), but not 5% Wnt3a-CM or 50% Wnt3a-CM (Fig. 
3.21 B,D,F). Spheroids grown in 5% Wnt3a-CM (P<0.001, Supplementary. 6.5), 5% Wnt3a-
CM + DAPT (P<0.01, Supplementary. 6.5) and 50% Wnt3a-CM (P<0.05, Supplementary. 6.5) 
had significantly more Ki67 positive nuclei (One-Way ANOVA with Sidak’s post-hoc Test) 
than colonoids grown in the same conditions. Reduced Wnt3a had no effect on the percentage 






Figure 3.21: Effect of reduced Wnt3a-CM ± DAPT on the proportion of Ki67 positive nuclei in 
organoids on day 15 
Representative scanned images of A and D) spheroids and B and C) colonoids from the same patient 
stained for Ki67 after being grown in A-B) 10% Wnt3a-CM or C-D) 10% Wnt3a-CM + DAPT for 
11 d. Proliferating nuclei expressing Ki67 are stained brown, while Ki67 negative nuclei are stained 
blue. Images were taken at the following objectives A and D) 20x and C and E) 15x. Quantification 
of the percentage of Ki67 positive nuclei on day 15 in E) spheroids and F) colonoids treated with 
reduced Wnt3a-CM ± DAPT. *Significantly less Ki67 positive nuclei were present in colonoids 
grown in 10% Wnt3a-CM in the presence of DAPT (*P<0.05, unpaired Student’s t Test). DAPT had 
no effect on the number of Ki67 positive cells in spheroids (One-way ANOVA with Sidak’s post-hoc 
Test). Wnt3a had no effect on the percentage of Ki67 positive nuclei in spheroids, or colonoids either 
in the presence, or absence, of DAPT (One-way ANOVA with Sidak’s post-hoc Test). All values are 




3.4.5 Effect of reduced Wnt3a-CM ± DAPT on alcian blue positive cell 
expression 
The Notch pathway is known to promote differentiation of colonic epithelial stem cells 
towards the absorptive lineage via the upregulation of HES1 (Fre et al., 2005; van Es et al., 
2005). However, DAPT had no effect on goblet cell differentiation in organoids grown in 
control conditions (Fan & Butt, pers. comm., unpublished). To test our hypothesis that this is a 
result of Wnt3a mediated upregulation of HES1, we used alcian blue staining to quantify alcian 
blue positive cells in colonoids grown in 5% Wnt3a-CM ± DAPT, 10% Wnt3a-CM ± DAPT or 
50% Wnt3a-CM ± DAPT for 11 d. There were significantly more alcian blue positive cells in 
colonoids grown in 5% Wnt3a-CM + DAPT (27% ± 2.8, P<0.0001, Fig), 10% Wnt3a-CM + 
DAPT (16% ± 2.0, P<0.0001) and 50% Wnt3a-CM + DAPT (25% ± 2.6, P<0.0001) compared 
with colonoids grown in the absence of DAPT (4% ± 0.7, 6% ± 1.1 and 4% ± 0.7 respectively) 





Figure 3.22: Effect of reduced Wnt3a-CM ± DAPT on the proportion of alcian blue positive 
cells in colonoids on day 15 
Representative scanned images of colonoids from the same patient stained with alcian blue after 
being grown in A) 5% Wnt3a-CM or B) 5% Wnt3a-CM + DAPT for 11 d. Alcian blue positive 
cells have a blue cytoplasm with pink nuclei, whereas alcian blue negative cells have only pink 
nuclei. Red arrows indicate alcian blue positive cells with a goblet morphology, black arrows 
indicate alcian blue positive cells with an abnormal morphology and the orange arrow indicates 
the glycocalyx. Images were taken at the A) 40x and B) 30x objective. C) Quantification of the 
percentage of alcian blue positive cells in day 15 colonoids treated with reduced Wnt3a-CM ± 
DAPT. *Significantly more alcian blue positive cells were present when organoids were treated 
with DAPT (P****<0.0001, One-way ANOVA with Sidak’s post-hoc Test). Wnt3a had no effect 
on the percentage of alcian blue positive cells in colonoids either in the presence, or absence, of 







3.4.6 Effect of reduced Wnt3a-CM ± DAPT on MUC2 positive cell 
expression  
To confirm the DAPT mediated increase in alcian blue positive cells were true MUC2 
positive goblet cells, colonoids grown in reduced Wnt3a-CM ± DAPT were stained using 
immunofluorescence against MUC2 as described previously. Surprisingly treatment with 
DAPT had no significant effect on the percentage of MUC2 positive cells in colonoids (Fig. 
1.23), contradicting the alcian blue results (Fig. 1.22). In addition, Wnt3a had no significant 
effect on the percentage of MUC2 positive cells either in the presence, or absence, of DAPT 






Figure 3.23: Effect of reduced Wnt3a-CM + DAPT on the proportion of MUC2 positive cells 
in colonoids on day 15 
Representative scanned images of colonoids from the same patient stained for MUC2 after being 
grown in A) 10% Wnt3a-CM or B) 10% Wnt3a-CM + DAPT for 11 d. MUC2 positive cells have a 
green cytoplasm with blue nuclei, whereas MUC2 negative cells contain only blue nuclei. Arrows 
indicate MUC2 positive cells. Images taken with an Olympus BX51 camera at 20x objective. C) 
Quantification of the percentage of MUC2 positive cells in colonoids grown in experimental and 
control conditions. C) Quantification of the percentage of MUC2 positive cells in colonoids on day 
15. There was no significant effect of reduced Wnt3a on the percentage of MUC2 positive cells in 
colonoids on day 15 either in the presence, or absence, of DAPT (One-way ANOVA with Dunnett’s 






3.4.7 Effect of reduced Wnt3a-CM ± DAPT on MUC2 transcript 
expression  
Notch inhibition has no effect on the percentage of MUC2 positive cells in colonoids grown in 
high or low Wnt3a conditions. To confirm this finding, DAPT mediated changes on MUC2 
transcript levels were investigated. Consistent with our immunofluorescence results, DAPT had 
no significant effect on the expression of MUC2 in colonoids (Fig. 3.24). Furthermore, reduced 
Wnt3a concentration resulted in no statistically significant changes in MUC2 expression in 
colonoids (Fig. 3.24). The same morphology described previously was present, with reduced 
Wnt3a or DAPT having no obvious effect on this morphology.  
 
Figure 3.24: Effect of reduced Wnt3a-CM ± DAPT on MUC2 expression in colonoids on 
day 15 
Quantification of the fold change in MUC2 transcript levels in colonoids grown in control and 
experimental conditions. All changes were normalised to the geometric mean of the 
housekeeping genes β2M and RPLP0. All experimental changes are expressed relative to the 
50% Wnt3a-CM control. Statistical analysis was performed using an unpaired Students t Test 







The colonic lumen is an extremely noxious environment, containing the waste products 
of digestion as well as a vast microbiota (Capaldo et al., 2017). To maintain intestinal 
homeostasis, it is imperative a comprehensive physical and chemical barrier is in place to 
separate the internal and external environments (Capaldo et al., 2017). In the colon, the 
epithelial monolayer, stratified mucus layer, and intercellular TJs form the physical component 
of the barrier, preventing interaction of unwanted luminal material with the epithelium and 
underlying tissue (Capaldo et al., 2017). Secreted factors from secretory cells within the 
epithelium and lamina propria establish a chemical barrier, further limiting epithelial-microbial 
interaction (Capaldo et al., 2017; Martini et al., 2017). The critical importance of this barrier is 
clearly demonstrated in IBD, which commonly presents with dysfunction in the intestinal 
barrier. 
To study the colonic epithelial barrier in healthy and diseased states, researchers have 
previously been limited to cell lines and animal models, both of which have various limitations 
(Balimane & Chong, 2005; Seok et al., 2013; Takao & Miyakawa, 2015). Fortunately, intestinal 
organoids, a new model derived from human adult intestinal epithelial stem cells, offer an 
exciting new method of studying the intestinal epithelium, without the associated limitations of 
alternative models (Sato et al., 2009; Sato et al., 2011a). Organoids derived from the human 
small intestine are proving very successful, expressing mature epithelial cells in similar 
proportions to in vivo tissue (Lindeboom et al., 2018). Moreover, small intestinal organoids can 
maintain long-term growth without requiring exogenous Wnt3a due to the production of 
endogenous epithelial Wnts by Paneth cells (Sato et al., 2011b). Unfortunately, in order to 
maintain human colonic organoid cultures long term, they must be grown in a high Wnt3a 




only 2-5% of the total cells, which is a markedly small expression compared with the colon, 
where goblet cells represent ~50% of the total cells (Gersemann et al., 2009). In addition, our 
laboratory has shown that Notch inhibition has no effect on HES1, a downstream Notch 
effector, or goblet cell expression in colonic organoids, contradicting previous in vivo studies 
(Fan & Butt, pers. comm., unpublished; Fre et al., 2005; van Es et al., 2005; VanDussen et al., 
2012). 
 The aberrant lineage specification in colonic organoids may be a consequence of the 
media they are grown in. Currently, organoids are grown in a high Wnt3a media that represents 
the in vivo stem cell niche. High Wnt and Notch signalling in vivo is associated with the 
transition of intestinal epithelial cells to a cancerous phenotype, in which HES1 is high and 
ATOH1 is low (Kazanjian & Shroyer, 2011; Polakis, 2012). Specifically, high Wnt signalling 
can upregulate HES1 via the TCF/LEF complex or degrade the ATOH1 protein via GSK3β 
(Tsuchiya et al., 2007; Aragaki et al., 2008). Similarly, Notch signalling directly upregulates 
HES1 expression via the NICD (Fre et al., 2005; van Es et al., 2005). Given the high Wnt3a 
media colonic organoids are grown in, and high levels of endogenous Notch signalling in 
colonic organoids (Rodriguez & Butt pers. comm., unpublished), it was hypothesised ATOH1 
expression was being suppressed, resulting in reduced differentiation of TA cells into goblet 
cells.  
In this study, colonic organoids derived from human biopsy were utilised to manipulate 
lineage specification in colonic epithelial stem cells, with an aim of increasing goblet cell 
expression. In addition, the growth of human colonic organoids was characterised, and the 




4.2 Effect of Wnt and Notch modulation on goblet cell 
expression  
In vivo analysis has identified the differential expression of HES1 and ATOH1 is critical 
in the early differentiation of TA cells (Yang et al., 2001; Zecchini et al., 2005; Shroyer et al., 
2007). The canonical Wnt and Notch signalling pathways have been identified as a regulator of 
these transcription factors, promoting the downregulation of ATOH1 via an upregulation of 
HES1, and via the degradation of the ATOH1 protein by the Wnt kinase GSK3β (Tsuchiya et 
al., 2007; Aragaki et al., 2008; Rodilla et al., 2009; Peignon et al., 2011). We, therefore 
hypothesised that the high Wnt3a and Notch signalling in colonoids was driving differentiating 
TA cells to the absorptive lineage, at the expense of the secretory lineage.  
4.2.1 Endogenous epithelial Wnts 
The complete removal of Wnt3a from the organoid growth media had no effect on alcian 
blue positive, or MUC2 positive cell expression. Interestingly the removal of Wnt3a also had 
no significant effect on organoid proliferation or survival but did significantly decrease mean 
diameter. This was surprising given the critical role of Wnt3a in maintaining colonic epithelial 
stem cell proliferation and growth and suggested sufficient Wnt signalling was still occurring. 
It was first proposed this was due to Wnt3a remaining in the Matrigel™, as a result of 
inadequate washing out of the high Wnt3a media on day 4. However, this theory was refuted 
using a luciferase assay in conjunction with TOPFlash cells, which demonstrated no Wnt3a or 
Rspo was present in 0% Wnt3a-CM + 0% Rspo-CM media after being incubated with organoids 
(established in high Wnt3a media for 4 d) for 2 d.  Another explanation was that endogenous 
epithelial Wnts were being produced by the epithelial cells within organoids. In the small 
intestine, Paneth cells dispersed throughout the stem cell population secrete a range of growth 
factors critical in maintaining the stem cell niche, including Wnt3a and EGF (Sato et al., 




deep crypt secretory (DCS) cells, also found in the crypt base, play a similar role (Rothenberg 
et al., 2012; Sasaki et al., 2016). When DCS cells were ablated in the murine small intestine 
using diphtheria toxin (DT), a significant reduction in Lgr5+ stem cells by day 3, and a near-
complete loss by day 6 was observed (Sasaki et al., 2016). The authors suggested this was a 
combination of increased differentiation into the absorptive lineage, as more colonocytes were 
present, and increased stem cell apoptosis, with caspase-3 positive cells being present in the 
crypt base. Transcriptome analysis has also identified growth factors critical in stem cell 
maintenance are expressed by DCS cells including EGF, Dll1-4 and Notch1/2 (Rothenberg et 
al., 2012; Sasaki et al., 2016). Given DCS cells have been identified in murine colonoids, and 
ablation of these cells leads to death of the organoid culture, it is possible DSC cells in our 
human colonic organoids are producing Wnt to compensate for the loss of Wnt3a.  
The canonical Wnt pathway is critically dependent on Rspo, which significantly amplifies 
Wnt signalling. Therefore, organoids were grown in varying levels of Rspo in conjunction with 
0% Wnt3a-CM to mitigate any endogenous epithelial Wnt signalling. The complete removal of 
Wnt3a and Rspo from the growth media had no significant effect on the percentage of alcian 
blue positive cells, while MUC2 positive cell expression was increased in colonoids grown in 
0% Wnt3a-CM + 0% Rspo-CM or 0% Wnt3a-CM + 3% Rspo-CM. Contradictory to our first 
experiment, organoids grown in the absence of Wnt with normal Rspo had significantly 
increased alcian blue and MUC2 positive cells. As this result was inconsistent with previous 
findings it was difficult to determine whether a reduction in Rspo was having any effect. This 
may be a result of the inherent variation within the outbred human population. Of the three 
patients included in this experiment, two exhibited particularly high MUC2 staining across all 
experimental treatments, whereas one exhibited high alcian blue staining in the 0% Wnt3a + 
12% Rspo-CM group. In addition, another patient showed essentially no alcian blue or MUC2 




4.2.2 Aberrant mucin expression   
Notch inhibition in vivo alters lineage specification in the colon, promoting differentiation 
into goblet cells (van Es et al., 2005; VanDussen et al., 2012). This is consistent with our finding 
that treatment with DAPT, a Notch inhibitor, significantly increased the proportion of alcian 
blue positive cells in colonoids, but unexpectedly did not increase the number of MUC2 positive 
cells or MUC2 transcript expression. This disparity suggests Notch inhibition is increasing the 
number of cells which produce non-MUC2 mucins. In the colon, the primary secreted mucin is 
MUC2, although other secretory mucins such as MUC5 have been identified in colonic crypts, 
and in the stratified mucus layers (van Klinken et al., 1998; Walsh et al., 2013). MUC5 is 
categorised into two subsets; MUC5AC and MUC5B. MUC5AC is the primary secretory mucin 
of the stomach and respiratory tract and is not expressed in normal colonic tissue (Hovenberg 
et al., 1996; Babu et al., 2006; Sheehan et al., 2006). However, multiple studies have identified 
an increase in MUC5AC staining in colorectal cancers, often coinciding with a decrease in 
MUC2 expression (Carrato et al., 1994; Wang et al., 2017). Furthermore, in the murine 
respiratory epithelium, Notch signalling downregulates MUC5AC expression via interaction of 
Hes1 with the MUC5AC promotor (Ou-Yang et al., 2013). In contrast, MUC5B is present in 
the normal colon, co-localising with MUC2 in the colonic crypt base (van Klinken et al., 1998; 
Walsh et al., 2013). Like MUC5AC, MUC5B is highly expressed in colon cancer and colon 
cancer cell lines (Van Seuningen et al., 2000; Walsh et al., 2013). Given the high Wnt and 
Notch environment colonic organoids are grown in, it is possible colonoids are exhibiting a 
cancerous phenotype (Kazanjian & Shroyer, 2011; Polakis, 2012) accompanied by aberrant 




4.2.3 Insufficient goblet cell maturation 
Another potentially confounding factor was the difficulty of determining whether an 
alcian blue positive or MUC2 positive cell was a mature goblet cell. Mature goblet cells contain 
a densely packed theca in their apical domain that displaces the nucleus into the basal domain, 
giving the goblet cell its distinct goblet shape. When stained with alcian blue, mature goblet 
cells have cytoplasmic staining above the nucleus which extends to the apical domain, where 
staining becomes strong and granular. Alcian blue positive cells observed in this study were 
predominantly columnar, and only had alcian blue staining in the very apical region. In addition, 
these cells did not exhibit basal nuclei. This made it particularly difficult to determine whether 
these cells were mature goblet cells. Similar to alcian blue positive cells, MUC2 positive cells 
did not exhibit a goblet cell morphology, often being columnar in shape with no basal nuclei. 
This could indicate the alcian blue positive or MUC2 positive cells identified in colonoids are 
not mature goblet cells, instead being progenitor goblet cells called oligomucous cells. 
Oligomucous cells do not have a goblet morphology, instead still retaining their columnar 
phenotype. Importantly, oligomucous cells also produce mucins, and can, therefore, be 
visualised with alcian blue or anti-MUC2 immunohistochemistry (Cheng & Leblond, 1974; 
Karam, 1999). Similar to our alcian blue positive cells, oligomucous cells have reduced mucus 
production, containing only two to three mucous globules in their apical region, a vast contrast 
to the ~40 found in mature goblet cells (Cheng & Leblond, 1974; Karam, 1999).  
The shared phenotype between oligomucous cells and the alcian blue/MUC2 positive 
cells observed in this study suggests modulation of Wnt3a and Notch signalling is insufficient 
to promote the differentiation of TA cells into mature goblet cells in human colonic organoids. 
There are a range of other factors that are not present in organoid growth media, or may be 
aberrantly expressed in colonic organoids, which are known to promote goblet cell development 




factors such as interleukin-4 (IL-4) and IL-13, as well as microbial metabolites including 
lipopolysaccharide (LPS) and flagellin (Becker et al., 2013; Dabbagh et al., 1999; Iwashita et 
al., 2003; Katz et al., 2002; Marillier et al., 2008; Steenwinckel et al., 2009).  
Of these factors, KLF4 is known to be critical in the maturation of goblet cells (Katz et 
al., 2002). In KLF4-/- mice, colonic goblet cell expression falls to ~2%, consistent with the 
expression in colonoids. These goblet cells also exhibit a strikingly similar phenotype to the 
majority of the goblet cells observed in colonoids (Katz et al., 2002). Specifically, these KLF4-
/- alcian blue positive cells were columnar with only apical staining present, more consistent 
with an oligomucous cell than a mature goblet cell (Katz et al., 2002). KLF4 expression is 
downregulated by Wnt, via TCF4, in colon cell lines (Flandez et al., 2006, Flandez et al., 2008). 
Furthermore, KLF4 expression is significantly decreased in human colon cancer. Therefore, 
organoids grown in a high Wnt media, which is associated a cancerous phenotype in intestinal 
epithelial cells, may have downregulated KLF4 expression, resulting in aberrant goblet cell 
maturation (Patel et al., 2010; Polakis, 2012).   
The lack of a microbiota may also be impeding the maturation of goblet cells in colonoids 
(Becker et al., 2013). Treatment with flagellin downregulated the transcription factors Hes1 
and Klf4 in a colonic cell line, both of which were also significantly downregulated in the colon 
of wild type mice compared with germ free mice (Becker et al., 2013). The microbial metabolite 
LPS has been linked to goblet cell differentiation, with LPS treated colonic organoids in our 
laboratory expressing a significant increase in alcian blue positive cells (Samuel & Butt, pers. 
comm., unpublished). Moreover, in germ-free mice the number and size of colonic goblet cells 
is significantly decreased, however, these goblet cells did exhibit a mature phenotype (Kandori 
et al., 1996; Ishikawa et al., 1989). Interestingly, mice deficient in TLR4, a receptor for LPS, 




and downregulation of Hes1, in the small intestine (Sodhi et al., 2012). Although these findings 
are contradictory, highlighting the complexity of this system, they demonstrate microbial 
metabolites modulate goblet cell development in the mammalian intestine.  
A lack of endogenous factors in the organoid growth media may affect mucin synthesis, 
resulting in the observed phenotype. Goblet cells derive their unique goblet shape due to the 
densely packed theca in the apical domain (Cheng & Leblond, 1974; Karam, 1999). The theca 
expands this compartment while displacing the nucleus into the basal domain, forming a goblet 
morphology (Cheng & Leblond, 1974; Karam, 1999). The alcian blue positive and MUC2 
positive cells observed in colonoids very rarely exhibited this phenotype. Immunological 
factors have not only been identified as regulators of goblet cell differentiation, but also mucin 
production. IL-4 and IL-13, secreted by intraepithelial and subepithelial immune cells, both 
promote goblet cell differentiation in the murine colon, as well as upregulating MUC2 
expression in colon cell lines (Dabbagh et al., 1999; Iwashita et al., 2003; Marillier et al., 2008). 
While IL-13 has an obvious role in protecting the intestinal mucosa against helminths, in which 
increased goblet cell activity is beneficial, the vast reduction in goblet cells in IL-13-/- indicate 
the role of IL-13 goes beyond protection, also regulating normal intestinal homeostasis 
(Marillier et al., 2008). Therefore, a lack of IL-4 and IL-13 in the organoid growth media may 
explain the low level of both goblet cells, and mucin staining seen in alcian blue positive and 
MUC2 positive cells.  
It is also possible factors included in the organoid growth media may be inhibiting goblet 
cell maturation. In particular, the P38 inhibitor SB202190 may be having this effect. P38 is a 
tumour suppressor involved in regulating proliferation and differentiation in the colonic 
epithelium (Otsuka et al., 2010). The addition of SB202190 significantly increases the plating 




proliferation and decreased apoptosis (Ventura et al., 2007; Sato et al., 2011a). Interestingly, 
when SB202190 was removed from organoid growth media, along with the removal of 
nicotinamide and addition of Dibenzoazepine (DBZ, γ-secretase inhibitor), goblet cell 
expression was significantly increased in human colonic organoids (Sato et al., 2011a). 
Furthermore, pharmacological or genetic inhibition of p38 in the murine colon and small 
intestine results in a reduction in goblet cell expression, and a decrease in proliferation (Otsuka 
et al., 2010; Wakeman et al., 2012b). These findings suggest the removal of SB202190, after 
adequate establishment of isolated colonic epithelial stem cells, may be required to increase the 
expression of mature goblet cells in colonic organoids.  
4.2.4 Co-localisation of alcian blue and MUC2 positive cells 
In addition to difficulty identifying mature goblet cells, the alcian blue positive and MUC2 
positive cells in colonoids were often observed co-localising. To quantify the expression of 
goblet cells, 4 µm transverse sections of organoids were stained using histology or 
immunofluorescence. The number of goblet cells in each colonoid within each 4 µm section 
was then counted and the average goblet cell expression for that section determined. This 
method is used based on the assumption goblet cells are evenly distributed throughout the 
tissue, and a 4 µm section is representative of the whole organoid. However, co-localisation of 
alcian blue and MUC2 positive cells suggests they are not evenly distributed within colonoids. 
If this is the case the current method of quantifying these cells is insufficient, and alternative 
methods such as whole mount analysis, serial sectioning or fluorescence-activated cell sorting 




4.3 Effect of Wnt and Notch modulation on organoid 
proliferation and size 
When grown in organoid growth media, spheroids express significantly more Ki67 
positive nuclei compared with colonoids, consistent with the higher rates of proliferation 
observed in spheroids observed in this study. This suggests the spheroid cells represent TA 
cells, while colonoids represent the mature epithelium found in the crypt surface. Wnt signalling 
critically regulates intestinal epithelial stem cell proliferation in vivo, with disruption of this 
pathway resulting in a significant reduction in these stem cells and a subsequent flattening of 
the villi (Fevr et al., 2007). Interestingly, when Wnt3a was removed from colonic organoids, 
no significant difference in the percentage of Ki67 positive nuclei or organoid survival was 
observed. This may be due to the secretion of endogenous Wnts as described previously. This 
theory is further supported by the observation that the complete withdrawal of Wnt3a and Rspo 
decreases the number of Ki67 positive nuclei in colonic organoids to near 0%. This result was 
not observed in colonic organoids grown in 0% Wnt3a-CM + 12% Rspo-CM or 0% Wnt3a-
CM + 3% Rspo-CM, of which both groups had a similar number of Ki67 positive nuclei, 
suggesting stem cells in colonic organoids are maintained in the absence of Wnt3a-CM, but 
only in the presence of Rspo.  
Organoids grown in 0% Wnt3a-CM, 5% Wnt3a-CM and 10% Wnt3a-CM were 
significantly smaller compared with the control, despite no change in proliferation being 
observed. Furthermore, the addition of DAPT significantly decreased the size of colonoids, but 
not spheroids, with only colonoids grown in 10% Wnt3a-CM + DAPT exhibiting a significant 
reduction in the number of Ki67 positive cells. A change in mean diameter indicates fewer cells 
are present within the organoid, as no obvious changes in cell size were observed. A reduction 
in the number of cells in an organoid could be a result of reduced proliferation or increased cell 




be expected, especially in spheroids, but this would have to be confirmed with analysis of 
apoptosis. This may be a result of the small sample size of spheroids analysed for proliferation. 
As described previously, over the 11 d experimental period a majority of spheroids differentiate 
into colonoids, with ~30% remaining on day 4 compared with day 15. This resulted in very few 
spheroids being present on day 15, ranging from 20 to as little as three spheroids per section. 
The reduced spheroid sample size may, therefore, be confounding our Ki67 data. Once 
spheroids have differentiated into colonoids, the proportion of Ki67 positive nuclei drops from 
~30% to ~10% (Van Hout & Butt pers. comm., unpublished). The intrinsically low proportion 
of Ki67 positive nuclei in colonoids may have also been a confounding factor. This low intrinsic 
expression may have made it difficult to observe any reduction in the expression of Ki67 
positive nuclei, potentially explaining why no significant reduction was observed in 
experimental conditions. 
4.4 Characterisation of organoid growth  
In this study, we characterised the growth of human colonic organoids in organoid growth 
media which contained 50% Wnt3a-CM + 12% Rspo-CM. We found that over the experimental 
period the relative number of spheroids decreased by ~70%, whereas the relative number of 
colonoids increased by ~36%. Overall the relative number of organoids decreased by ~40%. 
This suggests two things may be occurring; organoids are dying and/or spheroids are merging 
to form colonoids. While death will likely be occurring in the culture, this seems an unlikely 
explanation for such a marked loss of organoids. Debris was often observed in the lumen of 
intact organoids, although this was most likely sloughed off surface cells. Debris was not 
present outside of the lumen, and very little debris was present in the culture wells over the 
experimental period, both of which suggest significant cell death is not occurring. This would 




It is generally agreed that the simple squamous epithelium comprising spheroids 
differentiates into the columnar epithelium characteristic of colonoids. However, such a marked 
loss of spheroids without significant cell death suggests they are merging, then differentiating 
to form colonoids. In support of this hypothesis, we occasionally observed spheroids which 
appeared to be merging. In one instance two merging spheroids appeared to be differentiating 
into a colonoid, supporting the idea merged or merging spheroids differentiate into colonoids 
(Fig. 3.1 C). This finding offers a potential explanation for the increase in colonoids and 
decrease in spheroids observed over the experimental period. It is possible, however, that these 
spheroids are not merging, but separating via budding. Confirming whether merging or budding 
is occurring could be investigated by visually tracking the growth of organoids using a camera 
mounted in the incubator.  
4.4.1 Effect of Wnt and Notch modulation on organoid growth  
The modulation of Wnt signalling had no effect on the differentiation of spheroids to 
colonoids; a surprising result given loss of function mutations in vivo increase the 
differentiation of TA cells to enterocytes (Fevr et al., 2007). This may be due to dysregulated 
Notch signalling. In the native tissue secreted proteins in the colonic crypt base are hypothesised 
to regulate notch signalling (Yang et al., 2011). One example is Numb, which is present in 
colon cancer cell lines, where it downregulates Notch signalling (Yang et al., 2011). A lack of 
these intrinsic regulators of Notch signalling may result in a higher degree of signalling than 
seen in vivo, partially compensating for the loss of Wnt signalling. Compensation may also be 
occurring via other additives in the organoid media. SB202190 is an additive that is required 
for the long-term culture of human colonic organoids (Ventura et al., 2007; Sato et al., 2011a). 
Therefore, it is possible this inhibitor, which is not naturally found in the body, can compensate 
for a loss of Wnt signalling. Interestingly organoids grown in the absence of Wnt in conjunction 




well. In addition, these organoids were more fragile than the control, appearing more 
fragmented after embedding in paraffin wax. Increased fragility of colonoids may indicate 
abnormal cell-cell junctions are forming. Wnt signalling has been implicated in the regulation 
of adherens junctions, which strongly adhere neighbouring cells (Miwa et al., 2001; Nelson & 
Nusse, 2004). Specifically, β-catenin is a component of the adherens junction, linking the 
transmembrane E-cadherin to the actin cytoskeleton via α-cadherin (Nelson & Nusse, 2004). A 
loss of β-catenin in the absence of Wnt signalling may result in an abnormal adherens junction, 
leading to more fragile cell-cell interactions that are prone to breaking.  
The inhibition of Notch signalling significantly increased the relative number of 
colonoids, and significantly decreased the relative number of spheroids grown in 5% Wnt3a-
CM + DAPT compared with organoids grown in 5% Wnt3a-CM. Given the lack of debris 
present in the culture well of 5% Wnt3a-CM + DAPT, this result suggests Notch inhibition in 
colonic organoids grown in low Wnt3a conditions drives the differentiation of TA cells into 
mature epithelial cells. Interestingly, this was not observed in organoids grown in 10% Wnt3a-
CM ± DAPT or 50% Wnt3a-CM ± DAPT. This result was unexpected, given Notch inhibition 
in vivo drives the differentiation of TA cells into goblet cells (van Es et al., 2005; VanDussen 
et al., 2012). This may be due to the high Wnt signalling occurring in the 10% Wnt3a-CM and 
50% Wnt3a-CM groups. As discussed previously, high Wnt signalling inhibits the 
differentiation of TA cells, which rapidly differentiate into absorptive cells in the absence of 
Wnt. Furthermore, our luciferase results demonstrated organoids grown in 50% Wnt3a-CM 
utilise ~1/3 of the available Wnt. Therefore, the concentration of Wnt3a in 10% Wnt3a-CM and 
50% Wnt3a-CM, but not in 5% Wnt3a-CM, may be high enough to compensate for the loss of 
Notch signalling, maintaining the stem cell niche. Compensation by high Wnt3a signalling may 




It is important to note that colonoids grown in the presence of DAPT appeared to grow 
inside out more frequently. An inside out colonoid was defined as an alcian blue stained 
colonoid with a continuous glycocalyx on the ‘outside’. This suggests Notch plays a role in the 
structural organisation of the intestinal crypt, although no structural abnormalities in the 
intestine of DAPT treated mice have been observed. 
4.5 Conclusions 
The primary aim of this study was to investigate whether modulation of Wnt and Notch 
signalling could increase goblet cell expression in human colonic organoids. While the 
modulation of Wnt and Notch signalling increased the expression of goblet cell markers, 
indicating an increase in goblet cell expression, it does not appear these cells are mature, being 
more structurally similar to immature oligomucous cells. This demonstrates the modulation of 
Wnt and Notch signalling in an in vitro model of the colonic epithelium is insufficient to 
promote the differentiation of colonic epithelial stem cells to mature goblet cells. It is likely 
additional factors found in vivo, such as KLF4 and LPS, or the removal of factors within 
organoid growth media, such as SB202190, is required to drive full goblet cell maturation in 
human colonic organoids.   
Additionally, this study characterised the growth of human colonic organoids in organoid 
growth media over a 15 d period and quantified the effect of Wnt and Notch modulation on this 
growth. Over the experimental period, the relative number of spheroids and total organoids 
decreases, while the relative number of colonoids increases. Given the lack of debris in the 
culture, this finding supports the hypothesis that spheroids are differentiating into colonoids. 
Furthermore, this finding provides evidence that spheroids can merge to form a single colonoid. 
Modulation of Wnt and Notch signalling had varied effects on organoid growth, although never 




supports our primary conclusion, demonstrating that in an in vitro model of the colonic 
epithelium, the modulation of Wnt and Notch signalling is insufficient to elicit the same 
changes seen in vivo. Similarly, to goblet cell development, it is likely the presence, or absence, 
of factors in colonic organoids, or organoid growth media, are involved. 
4.6 Limitations 
One of the main limitations of this study was the difficulty identifying goblet cells in 
alcian blue stained colonoids. The primary observed morphology of alcian blue positive cells 
did not reflect that of mature goblet cells, being columnar in shape with no basal nuclei and 
only apical staining. This made it particularly hard to determine whether the cell was a true 
goblet cell or an immature oligomucous. The identification of MUC2 positive cells was easier 
than in alcian blue sections as only MUC2 was being stained. However, MUC2 positive cells 
exhibited a similar phenotype to alcian blue positive cells, and it was therefore difficult to 
determine if the cell was a true mature goblet cell. Additionally, in colonoids in which goblet 
cell expression was high, fluorescent staining was high making it difficult to differentiate 
between MUC2 positive and negative cells. This may have been due to the variation within 
the outbred human population. 
In addition to difficulty with identification, alcian blue positive and MUC2 positive 
cells were often co-localised. This suggests in colonoids these cells are not as evenly 
distributed as they are in the native tissue. As the method of quantifying positive cells 
involved counting positive and negative cells in a transverse section of a colonoid, unevenly 
distributed cells would confound our results.  
Another limitation of this study was the low level of spheroids present on day 15. This 
was particularly evident when investigating proliferation, with only 3-20 spheroids being 




variation in the percentage of Ki67 positive nuclei, and the lack of significance, that was 
observed. In addition, any reduction in the expression of Ki67 positive nuclei in colonoids 
may have been difficult to observe, as colonoids have an intrinsically low proportion of Ki67 
positive nuclei, potentially confounding the results.  
4.7 Future Directions 
The results from this research project were interesting and lay the foundations for further 
research into the modulation of lineage development in the colonic epithelium.  
An initial step to build on the current results would be to confirm Wnt and Notch 
signalling were being altered in experimental conditions. This could be done using Western 
blot analysis for the Wnt effector β-catenin, and qPCR of the Wnt independent Notch 
downstream target OLFM4. To ensure Wnt signalling is being inhibited, organoids could be 
treated with Dkk1, a Wnt inhibitor, in place of varying Wnt3a-CM and Rspo-CM. In addition, 
qPCR analysis of ATOH1 and HES1 expression in low Wnt and Notch conditions would need 
to be carried out to substantiate the results from this study. Alternatively, in situ hybridisation 
chain reaction (HCR), which allows up to four different mRNA to be fluorescently tagged, 
could be used to assess the modulation of Wnt and Notch signalling on goblet cell development 
by tagging, for example, HES1, ATOH1, MUC2 and TCF4 (Choi et al., 2018). 
Our primary conclusion from this study suggested modulation of Wnt and Notch was not 
sufficient to promote goblet cell maturation in human colonic organoids, and likely requires the 
addition, or removal, of various factors. An important subsequent step would be to confirm the 
alcian blue positive and MUC2 positive cells observed in this study were immature goblet cells. 
To do this electron microscopy could be used to investigate the structure of these cells, 
comparing them with mature goblet cells. In addition, double immunofluorescence for MUC2 




HCR could also be used to identify multiple goblet and stem cell markers such as MUC2, TFF3 
(a goblet cell marker), KLF4 (mature goblet cell marker) and LGR5 (intestinal epithelial stem 
cell marker) (Choi et al., 2018). Investigating the role of other factors in goblet cell maturation 
is also a clear next step. This work has begun in our lab, showing LPS can increase goblet cell 
expression in human colonic organoids. The next step is to investigate different microbial 
metabolites, such as flagellin, as well as other endogenous factors such as IL-4/13. Additionally, 
modulation of the transcription factor KFL4 in colonic organoids may increase goblet cell 
expression.  
One of the limitations of this study was alcian blue positive and MUC2 positive cells 
appeared to co-localise, suggesting they were not evenly distributed through the tissue unlike 
goblet cells in vivo. Determining if these cells are truly co-localised is important to ensure the 
best method of quantification is used. This could be investigated using whole mounting of 
organoids, which would allow visualisation of MUC2 positive cells within the whole organoid. 
Alternatively, single organoids, either embedded in paraffin wax or mounted, could be serially 
sectioned using histology or confocal optical sections respectively, allowing the whole organoid 
to be analysed. If alcian blue positive and MUC2 positive cells were found to co-localise these 
methods, as well as FACS, would be more appropriate for the quantification of goblet cells in 
human colonic organoids.  
While this project focuses on creating a model that is structurally representative of the 
colonic epithelium, it is also critical the functional characteristics of colonic organoids are 
elucidated. Although organoids are an exciting new model, very little research has been done 
to characterise the functional properties of this model. This creates a problem in that researchers 
are conducting research using organoids that may not be as representative as initially thought. 




qPCR or Western blot, as well as the functional characteristics of these proteins using 
electrophysiology would be beneficial to further elucidate the similarities, and differences, 
between human colonic organoids and human colonic tissue (Aragaki et al., 2008).  
Characterising the structual and functional properties of colonic organoids derived from  
patients that have no evidence of intestinal disease is an important first step in the use of 
organoids in studying barrier related diseases, such as IBD. Once characterised, organoids 
derived from patients suffering from barrier related diseases can then be compared with healthy 
colonic organoids, elucidating any differences in the structure and function of the colonic 
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Experiment 1: Reduced Wnt3a-CM 
 
Supplementary Figure 6.1: Effect of reduced Wnt3a-CM on the proportion of Ki67 positive 
nuclei in organoids on day 15 
Quantification of the percentage of Ki67 positive nuclei in spheroids and colonoids grown in 
experimental and control conditions for 11 d. There was no significant difference in the percentage 
of Ki67 positive nuclei between spheroids and colonoids (One-way ANOVA with Dunnett’s post-





Experiment 2: 0% Wnt3a-CM + reduced Rspo-CM 
 
Supplementary Figure 6.2: Effect of reduced Wnt3a-CM + varying Rspo-CM on the 
proportion of Ki67 positive nuclei in organoids on day 15 
Quantification of the percentage of Ki67 positive nuclei in spheroids and colonoids grown in 
experimental and control conditions for 11 d. There was no significant difference in the percentage 
of Ki67 positive nuclei between spheroids and colonoids (One-way ANOVA with Dunnett’s post-





Experiment 3: Reduced Wnt3a-CM ± DAPT 
 
Supplementary Figure 6.3: Effect of reduced Wnt3a-CM ± DAPT on the relative number of 
organoids on days 4 and 15 
Quantification of the effect of varying Wnt3a ± DAPT on the relative number of A) spheroids and B) 
colonoids. *Significantly more colonoids, and less spheroids, were present when grown in 5% Wnt3a-
CM + DAPT, 10% Wnt3a-CM ± DAPT and 5% Wnt3a-CM ±DAPT (**P<0.01, ****P<0.0001, One-
way ANOVA with Sidak’s post-hoc Test). DAPT had no significant effect on the relative number of 
spheroids or colonoids on day 4 (One-way ANOVA with Sidak’s post-hoc Test). In addition, Wnt3a 
had no effect on the relative number of spheroids and colonoids on day 4 either in the presence, or 






Supplementary Figure 6.4: Effect of reduced Wnt3a-CM ± DAPT on the mean diameter of 
organoids on days 4 and 15 
Quantification of the effect of varying Wnt3a ± DAPT on the mean diameter of A) spheroids and B) 
colonoids. DAPT had no significant effect on the mean diameter of spheroids or colonoids on day 4 
(One-way ANOVA with Sidak’s post-hoc Test). In addition, Wnt3a had no effect on the mean 
diameter of spheroids and colonoids on day 4 either in the presence, or absence of DAPT (One-way 
ANOVA with Sidak’s post-hoc Test). All values are mean ± SEM, N=3, n=205-289 day 4 spheroids, 






Supplementary Figure 6.5: Effect of varying Wnt3a-CM ± DAPT on the proportion of Ki67 
positive nuclei in organoids on day 15 
Quantification of the percentage of Ki67 positive nuclei in spheroids and colonoids grown in A) 
varying Wnt3a-CM and B) varying Wnt3a-CM + DAPT for 11 d. *Significantly more Ki67 positive 
nuclei were present in spheroids grown in 5% Wnt3a-CM and 50% Wnt3a-CM compared with 
colonoids town in the same conditions. There was no significant difference in the percentage of Ki67 
positive nuclei between spheroids and colonoids (One-way ANOVA with Sidak’s post-hoc Test). All 
values are mean ± SEM, N=3, n=7-20 spheroids, n=20-53 colonoids. 
 
 
 
 
